Shaoying Li, M.D.

Peer-Reviewed Articles

1. Wang, WJ, Lin, P, Stewart, J, Tang, G, Li, S, Loghavi, S, Medeiros, LJ, Xu, J. ALK+ Large B-Cell Lymphoma With Novel ZNF296::ALK: A Morphologic Mimic of ALK+ Anaplastic Large Cell Lymphoma. American journal of hematology 100(12):2371-2372, 2025. e-Pub 2025. PMID: 40423499.
2. Wang W, Cai Q, Liu Y, Nie L, Lee HH, Yan F, Fei Y, Yao Y, Li Y, Tan L, Lorenzi PL, Wang YN, Yao J, Chen Z, McIntosh JM, Yu CT, Jain P, Jiang VC, Vargas J, Li X, Zhang T, Li S, Santos D, Thirumurthi S, Seeley EH, Simon LM, Flowers C, Ok CY, Wang M. TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma. Blood 146(21):2544-2560, 2025. e-Pub 2025. PMID: 40700581.
3. Wei Q, Pemmaraju N, Wang SA, Hu S, DiNardo C, Issa GC, Bueso-Ramos CE, Xu J, Li S, Medeiros JL, Tang G. Acute myeloid leukemia with t(10;17)(p15;q21)/ZMYND11::MBTD1: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults. Haematologica, 2025. e-Pub 2025. PMID: 41262054.
4. E, S, Vega Vazquez, F, Khanlari, M, Fang, H, Xu, J, Li, S, Hu, S, Wang, S, Wei, Q, Wang, WJ, Medeiros, LJ, Wang, W. BCL11B helps to define T-lineage in lymphomas/leukaemias with a mixed/ambiguous immunophenotype. Pathology 57(6):746-752, 2025. e-Pub 2025. PMID: 40318959.
5. Gisriel SD, Yuan J, Tang H, Xu J, Fang H, Li S, McCracken J, Li P, Braunberger RC, Xu-Monette ZY, Wu X, Wang E, Zhang QY, Soma LA, Katz SG, Zhang JJ, Matsumoto NP, Young KH, Xu ML, Pan Z. Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study. Am J Clin Pathol 164(3):390-401, 2025. e-Pub 2025. PMID: 40581918.
6. Habib, D, Jabbour, EJ, Bataller Torralba, A, Sasaki, K, Tang, G, Loghavi, S, Li, S, Senapati, J, Short, NJ, Jain, N, Kantarjian, HM, Haddad, FG. Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18). Clinical Lymphoma, Myeloma and Leukemia 25(9):672-675, 2025. e-Pub 2025. PMID: 40222876.
7. Wang WJ, Wang SA, Fang H, Wei Q, Jorgensen JL, Hu S, Xu J, Li S, Tang G, Tang Z, Medeiros LJ, Wang W. Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype. Cytometry B Clin Cytom, 2025. e-Pub 2025. PMID: 40814768.
8. Sameeta, F, Wang, W, Jelloul, FZ, Nwogbo, OV, Thakral, B, Xu, J, Li, S, Ok, CY, Tang, G, Jia, F, Medeiros, LJ, Loghavi, S, Jorgensen, JL, Wang, SA. The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes. Archives of pathology & laboratory medicine 149(8):717-726, 2025. e-Pub 2025. PMID: 39711284.
9. Quintanilla-Martinez, L, Li, S, Chadburn, A. Epstein-Barr virus–positive T- and NK-cell lymphoproliferative disorders Report from the 2023 SH/eA4HP lymphoma workshop. American journal of clinical pathology 164(1):46-64, 2025. e-Pub 2025. PMID: 40619129.
10. Wang SA, Li S, Wang W, Xu J, Thakral B, Hu S, Ok CY, Jia F, Jorgensen JL, Medeiros LJ, Ravandi F, Short NJ, Loghavi S. Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort. Arch Pathol Lab Med, 2025. e-Pub 2025. PMID: 40522873.
11. Shuyu, E, Medeiros, LJ, Fang, H, Li, S, Tang, G, Wang, S, Wang, W, Yin, CC, You, MJ, Iyer, SP, Malpica Castillo, LE, Qiu, L, Tang, Z, Wei, Q, Lin, P, Xu, J. Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. Cancers 17(11), 2025. e-Pub 2025. PMID: 40507248.
12. Tang, G, Jain, P, Hu, S, Ok, CY, Wang, WJ, Quesada, AE, Wei, Q, Li, S, Xu, J, Loghavi, S, Toruner, GA, Medeiros, LJ. Optical genome mapping reveals diverse mechanisms of cyclin activation in mantle cell lymphomas lacking IGH::CCND1. Human Pathology 159, 2025. e-Pub 2025. PMID: 40381701.
13. Kim, DH, Medeiros, LJ, Xu, J, Tang, G, Qiu, L, Wang, S, Ok, CY, Wang, W, Yin, CC, You, MJ, Garces, S, Lin, P, Li, S. Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements. Modern Pathology 38(5), 2025. e-Pub 2025. PMID: 39805522.
14. Wei Q, Jelloul FZ, Wang SA, Tang G, Li S, Lin P, Loghavi S, Wang HY, Medeiros LJ, Xu J. Concurrent Bone Marrow Acute Undifferentiated Leukemia and Mediastinal T-Lymphoblastic Lymphoma With Identical SET::NUP214 Fusion and PHF6 and EZH2 Mutations. EJHaem 6(2):e70034, 2025. e-Pub 2025. PMID: 40264515.
15. Wei, Q, Hu, S, Loghavi, S, Toruner, GA, Ravandi-Kashani, F, Tang, Z, Li, S, Xu, J, Daver, N, Medeiros, LJ, Tang, G. Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia. American journal of hematology 100(3):417-426, 2025. e-Pub 2025. PMID: 39871121.
16. E S, Tang G, Li S, Schlette E, Wang SA, Xu J. Anaplastic large cell lymphoma with ATIC::ALK in leukemic phase and associated with hemophagocytic lymphohistiocytosis. Int J Lab Hematol 47(1):13-14, 2025. e-Pub 2025. PMID: 39109887.
17. Sameeta F, Wang SA, Tang Z, Khoury JD, Fang H, Wang D, Xu J, Li S, Hu Z, Hu S, Jorgensen JL, Medeiros LJ, Wang W. Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. Am J Clin Pathol 162(5):455-463, 2024. e-Pub 2024. PMID: 38801226.
18. Epperla N, Zayac AS, Landsburg DJ, Bock AM, Nowakowski GS, Ayers EC, Girton M, Hu M, Beckman A, Li S, Medeiros LJ, Chang JE, Kurt H, Sandoval-Sus J, Ansari-Lari MA, Kothari SK, Kress A, Xu ML, Torka P, Sundaram S, Smith SD, Naresh KN, Karimi Y, Bond DA, Evens AM, Naik SG, Kamdar M, Haverkos BM, Karmali R, Farooq U, Vose JM, Rubinstein P, Chaudhry A, Olszewski AJ. High-grade B-cell lymphoma, not otherwise specified. Blood Adv 8(20):5355-5364, 2024. e-Pub 2024. PMID: 39189932.
19. Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, Toruner GA, Wang SA, Wang W, Miranda RN, Li S, Xu J, DiNardo CD, Daver N, Kadia TM, Issa GC, Kantarjian HM, Medeiros LJ, Tang G. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. Am J Hematol 99(10):1959-1968, 2024. e-Pub 2024. PMID: 39016111.
20. Xu J, Kim DH, Wang W, Li S, Lin P, Tang G, Konoplev S, Qiu L, Fang H, Garces S, Leventaki V, E S, Medeiros LJ, Wang SA. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. Am J Clin Pathol 163(2):240-250, 2024. e-Pub 2024. PMID: 39244687.
21. E S, Xu J, Wang SA, Tang G, Jabbour EJ, Li S, You MJ, Medeiros LJ, Yin CC. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia. Am J Clin Pathol 163(2):231-239, 2024. e-Pub 2024. PMID: 39235991.
22. Kim DH, Wang SA, Wang W, Tang G, Li S, Yin CC, Lin P, Konopleva M, You MJ, Miranda RN, Wang X, Wei Q, Medeiros LJ, Xu J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica 109(8):2711-2715, 2024. e-Pub 2024. PMID: 38546693.
23. Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia. Am J Clin Pathol. e-Pub 2024. PMID: 38946194.
24. Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, Pierson DM, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RN. The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol 48(6):e43-e64, 2024. e-Pub 2024. PMID: 38451836.
25. Kim DH, Siddiqui S, Jain P, Wang M, Thakral B, Li S, Miranda R, Vega F, Medeiros LJ, Ok CY. TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present. Hum Pathol 146:1-7, 2024. e-Pub 2024. PMID: 38460798.
26. Quesada AE, Hu S, Li S, Toruner GA, Wei Q, Loghavi S, Ok CY, Jain P, Thakral B, Nwogbo OV, Kim D, Iyer SP, You MJ, Medeiros LJ, Tang G. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma. Hum Pathol 144:71-76, 2024. e-Pub 2024. PMID: 38301962.
27. Li S, Tang G, Jain P, Lin P, Xu J, Miranda RN, Cheng J, Yin CC, You MJ, Wang ML, Medeiros LJ. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?. Mod Pathol 37(2):100405, 2024. e-Pub 2024. PMID: 38104893.
28. Nahmod KA, Tang G, Li S, Torres-Cabala C, Xu J. Acquisition of TP63 Rearrangement in Large Cell Transformation of Mycosis Fungoides. EJHaem 5(1):264-265, 2024. e-Pub 2024. PMID: 38406547.
29. Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang M, Cohen JB, Churnetski M, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast M, Fenske T, Rao Gari SN, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns T, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Ristow K, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Adv 7(24):7393-7401, 2023. e-Pub 2023. PMID: 37874912.
30. Tang G, Wu Y, Lin P, Toruner GA, Hu S, Li S, Qazilbash MH, Orlowski RZ, Ye C, Xu J, Nahmod KA, Medeiros LJ, Tang Z. Cytogenetic Profile in Monoclonal Gammopathy of Undetermined Significance, Smoldering and Symptomatic Multiple Myeloma. Cancers (Basel) 15(23), 2023. e-Pub 2023. PMID: 38067393.
31. Qiu L, Lin P, Khanlari M, Xu J, Cohen EN, Garces S, Miranda RN, Wang W, Fang H, Bueso-Ramos CE, Medeiros LJ, Li S. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Mod Pathol 36(12):100349, 2023. e-Pub 2023. PMID: 37820764.
32. Zayac AS, Landsburg DJ, Hughes ME, Bock AM, Nowakowski GS, Ayers EC, Girton M, Hu M, Beckman AK, Li S, Medeiros LJ, Chang JE, Stepanovic A, Kurt H, Sandoval-Sus J, Ansari-Lari MA, Kothari SK, Kress A, Xu ML, Torka P, Sundaram S, Smith SD, Naresh KN, Karimi YH, Epperla N, Bond DA, Farooq U, Saad M, Evens AM, Pandya K, Naik SG, Kamdar M, Haverkos B, Karmali R, Oh TS, Vose JM, Nutsch H, Rubinstein PG, Chaudhry A, Olszewski AJ. High-grade B-cell lymphoma, not otherwise specified. Blood Adv 7(21):6381-6394, 2023. e-Pub 2023. PMID: 37171397.
33. Fang H, Li S. ALK+ ALCL with Erythroblast-like Cytology Diagnosed in Ascites in a Patient with History of B-Cell Lymphomas. Blood 142(19):1672, 2023. e-Pub 2023. PMID: 37944178.
34. Hong T, Li J, Guo L, Cavalier M, Wang T, Dou Y, DeLaFuente A, Fang S, Guzman A, Wohlan K, Kapadia C, Rosas C, Yang Y, Yin CC, Li S, You MJ, Cheng X, Goodell MA, Zhou Y, Huang Y. TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nat Aging 3(11):1387-1400, 2023. e-Pub 2023. PMID: 37884767.
35. Wang SA, Jorgensen JL, Hu S, Jia F, Li S, Loghavi S, Ok CY, Thakral B, Xu J, Medeiros LJ, Wang W. Validation of a 12-color Flow Cytometry Assay for Acute Myeloid Leukemia Minimal/Measurable Residual Disease Detection. Cytometry B Clin Cytom 104(5):356-366, 2023. e-Pub 2023. PMID: 37605812.
36. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. T-prolymphocytic leukemia. Leukemia 37(9):1919-1921, 2023. e-Pub 2023. PMID: 37443196.
37. Khanlari M, Mo H, Kim DH, Sakhdari A, Young KH, Jain P, Wang M, Li S, Kanagal-Shamanna R, Miranda RN, Vega F, Medeiros LJ, Ok CY. Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features. Am J Surg Pathol 47(8):849-858, 2023. e-Pub 2023. PMID: 37288826.
38. Li N, Lin P, Zuo Z, You MJ, Shuai W, Orlowski R, Manasanch EE, Li S, Xu J, Garces S, Jelloul FZ, Tang Z, Wang W, Medeiros LJ, Yin CC. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer Med 12(13):14293-14304, 2023. e-Pub 2023. PMID: 37212518.
39. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J. DUSP22 rearrangement is associated with distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica 108(6):1604-1615, 2023. e-Pub 2023. PMID: 36453104.
40. El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant. Virchows Arch 482(6):1011-1019, 2023. e-Pub 2023. PMID: 36864257.
41. El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma. Pathology 55(4):514-524, 2023. e-Pub 2023. PMID: 36933995.
42. Jelloul FZ, Quesada AE, Yang RK, Li S, Wang W, Xu J, Tang G, Yin CC, Fang H, El Hussein S, Khoury J, Bassett RL, Garcia-Manero G, Manasanch EE, Orlowski RZ, Qazilbash MH, Patel KP, Medeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies. Mod Pathol 36(6):100166, 2023. e-Pub 2023. PMID: 36990279.
43. Hoppe MM, Jaynes P, Shuangyi F, Peng Y, Sridhar S, Hoang PM, Liu CX, De Mel S, Poon L, Chan EHL, Lee J, Ong CK, Tang T, Lim ST, Nagarajan C, Grigoropoulos NF, Tan SY, Hue SS, Chang ST, Chuang SS, Li S, Khoury JD, Choi H, Harris C, Bottos A, Gay LJ, Runge HFP, Moutsopoulos I, Mohorianu I, Hodson DJ, Farinha P, Mottok A, Scott DW, Pitt JJ, Chen J, Kumar G, Kannan K, Chng WJ, Chee YL, Ng SB, Tripodo C, Jeyasekharan AD. Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer Discov 13(5):1144-1163, 2023. e-Pub 2023. PMID: 37071673.
44. Tang G, Li S, Toruner GA, Jain P, Tang Z, Hu S, Xu J, Cheng J, Robinson M, Vega F, Medeiros LJ. Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas. Cancer Genet 272-273:1-8, 2023. e-Pub 2023. PMID: 36566629.
45. Xu J, Li S, Yin CC, Patel KP, Tang G, Wang W, Miranda RN, Garces S, Tang Z, Lin P, Medeiros LJ. Classic Hodgkin lymphoma with marked granulomatous reaction. Hum Pathol 134:114-123, 2023. e-Pub 2023. PMID: 36584716.
46. Shuai W, Zuo Z, Li N, Garces S, Jelloul FZ, Ok CY, Li S, Xu J, You MJ, Wang W, Rehder C, Jabbour EJ, Patel KP, Medeiros LJ, Yin CC. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129(6):878-889, 2023. e-Pub 2023. PMID: 36583229.
47. Qiu L, Wang SA, Tang G, Wang W, Lin P, Xu J, Yin CC, Khanlari M, Medeiros LJ, Li S. Blastoid B-Cell Neoplasms: Diagnostic Challenges and Solutions. Cancers (Basel) 15(3), 2023. e-Pub 2023. PMID: 36765805.
48. Li S, Qiu L, Xu J, Lin P, Ok CY, Tang G, McDonnell TJ, James You M, Khanlari M, Miranda RN, Medeiros LJ. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37(2):422-432, 2023. e-Pub 2023. PMID: 36513804.
49. Wang Y, Quesada AE, Zuo Z, Medeiros LJ, Yin CC, Li S, Xu J, Borthakur G, Li Y, Yang C, Abaza Y, Gao J, Lu X, You MJ, Zhang Y, Lin P. The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation. Cancers (Basel) 15(1), 2023. e-Pub 2023. PMID: 36612194.
50. Qiu L, Nwogbo OV, Medeiros LJ, Thakral B, Li S, Xu J, You MJ, Wang W, Quesada AE, Ramos CB, McDonnell TJ, Thomas SK, Lin P. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein. Hum Pathol 130:47-57, 2022. e-Pub 2022. PMID: 36244464.
51. Fang H, Khoury JD, Torres-Cabala CA, Ng SB, Xu J, El Hussein S, Hu S, Vega F, Li S, Tang Z, Tang G, Medeiros LJ, Wang W. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology 54(7):893-899, 2022. e-Pub 2022. PMID: 35864006.
52. Garces S, Rudzki Z, Yin CC, Miranda RN, Medina AM, Sriganeshan V, Cuglievan B, Li S, Xu J, Jelloul F, Khoury JD, Thakral B, Tang G, Garces JC, Medeiros LJ. MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy. Am J Surg Pathol 46(11):1514-1523, 2022. e-Pub 2022. PMID: 35877199.
53. Wang X, Lin P, Xu J, Li S. Diffuse large B-cell lymphoma with phenotype switch, anaplastic features and aberrant T-cell marker expression during disease evolution. EJHaem 3(4):1402-1403, 2022. e-Pub 2022. PMID: 36467806.
54. Xie W, Medeiros LJ, Li S, Tang G, Fan G, Xu J. PD-1/PD-L1 Pathway. Biomedicines 10(7), 2022. e-Pub 2022. PMID: 35884893.
55. Tang G, Zou Y, Wang SA, Borthakur G, Toruner G, Hu S, Li S, Xu J, Medeiros LJ, Tang Z. 3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant. Ann Hematol 101(4):847-854, 2022. e-Pub 2022. PMID: 35184217.
56. Khanlari M, Li S, Miranda RN, Iyer S, Konoplev S, Lin P, Yin CC, Tang G, Qiu L, Vega F, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol 35(3):412-418, 2022. e-Pub 2022. PMID: 34628481.
57. Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M, Research Group MC, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1). Lancet Oncol 23(3):406-415, 2022. e-Pub 2022. PMID: 35074072.
58. Konoplev S, Wang X, Tang G, Li S, Wang W, Xu J, Pierce SA, Jia F, Jorgensen JL, Ravandi F, Issa GC, Medeiros LJ, Wang SA. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults. Cytometry B Clin Cytom 102(2):123-133, 2022. e-Pub 2022. PMID: 34964255.
59. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow. Mod Pathol 35(3):419-426, 2022. e-Pub 2022. PMID: 34608246.
60. Garces S, Medeiros LJ, Marques-Piubelli ML, Coelho Siqueira SA, Miranda RN, Cuglievan B, Sriganeshan V, Medina AM, Garces JC, Saluja K, Bhattacharjee MB, Khoury JD, Li S, Xu J, Jelloul FZ, Thakral B, Cameron Yin C. Cyclin D1 expression in Rosai-Dorfman disease. Hum Pathol 121:36-45, 2022. e-Pub 2022. PMID: 34995673.
61. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation. Ann Diagn Pathol 56:151860, 2022. e-Pub 2022. PMID: 34823075.
62. Li S, Xu J, Yin CC, Konoplev S. Richter Transformation with Marked Plasmacytic Differentiation, Mimicking Plasma Cell Neoplasm. EJHaem 3(1):241-242, 2022. e-Pub 2022. PMID: 35846217.
63. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle cell lymphoma with chronic lymphocytic leukemia-like features. Hum Pathol 119:59-68, 2022. e-Pub 2022. PMID: 34767860.
64. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
65. Martinez-Baquero D, Sakhdari A, Mo H, Kim DH, Kanagal-Shamanna R, Li S, Young KH, O'Malley DP, Dogan A, Jain P, Wang ML, McDonnell TJ, Miranda RN, Vega F, Medeiros LJ, Ok CY. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma. Mod Pathol 34(12):2183-2191, 2021. e-Pub 2021. PMID: 34376807.
66. Yin CC, Pemmaraju N, You MJ, Li S, Xu J, Wang W, Tang Z, Alswailmi O, Bhalla KN, Qazilbash MH, Konopleva M, Khoury JD. Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 13(23), 2021. e-Pub 2021. PMID: 34884997.
67. Qiu L, Tang G, Li S, Wang W, Wang SA, Xu J. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor lymphoblastic leukemia. EJHaem 4(2):895-896, 2021. e-Pub 2021.
68. Jain P, Kanagal-Shamanna R, Zhang S, Ok CY, Navsaria L, Nastoupil L, Lee HJ, Tang G, Yin CC, Badillo M, Nair R, Li S, Patel KM, Flowers C, Vega F, Wang L, Wang ML. Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. Am J Hematol 96(5):E137-E140, 2021. e-Pub 2021. PMID: 33491779.
69. Wang L, Tang G, Medeiros JL, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S. MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106(5):1381-1389, 2021. e-Pub 2021. PMID: 32273477.
70. Morse DC, Park KE, Chitsazzadeh V, Li S, Young K, Gunther JR, Dabaja BS, Duvic M. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma. Int J Gynecol Pathol 40(3):229-233, 2021. e-Pub 2021. PMID: 33741766.
71. Wang W, Khoury JD, Miranda RN, Jorgensen JL, Xu J, Loghavi S, Li S, Pemmaraju N, Nguyen T, Medeiros LJ, Wang SA. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106(4):1047-1055, 2021. e-Pub 2021. PMID: 32241840.
72. Hao S, Lu X, Gong Z, Bassett RL, Hu S, Konoplev SN, Tang G, Li S, Xu J, Khanlari M, Lee HC, Manasanch EE, Weber DM, Orlowski RZ, Jeffrey Medeiros L, Lin P. The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma. Mod Pathol 34(2):327-335, 2021. e-Pub 2021. PMID: 32908255.
73. Ronaghy A, Hu S, Tang Z, Wang W, Tang G, Loghavi S, Li S, Thakral B, Medeiros LJ, Muzzafar T. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities. Mod Pathol 34(2):300-313, 2021. e-Pub 2021. PMID: 33110238.
74. Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma:1-12. e-Pub 2021. PMID: 33480830.
75. Jain P, Tang G, Li S, Wang M. "Triple hit" SOX11- , MME+ , TP53 mutated high-grade pleomorphic mantle cell lymphoma. Am J Hematol 96(1):165-166, 2021. e-Pub 2021. PMID: 32356355.
76. Khanlari M, Tang G, Hao S, Gong Y, Li S, Miranda RN, Lin P, Iyer S, Yin CC, Xie W, Vega F, Medeiros LJ, Xu J. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192(1):e17-e21, 2021. e-Pub 2021. PMID: 33216956.
77. Chen Z, Hu S, Wang SA, Konopleva M, Tang Z, Xu J, Li S, Toruner G, Thakral B, Medeiros LJ, Tang G. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia. Leuk Lymphoma 61(12):2831-2838, 2020. e-Pub 2020. PMID: 32700989.
78. Lyapichev KA, Tang G, Li S, You MJ, Cheng TJ, Miranda RN, Iyer S, Yin CC, Konoplev S, Bueso-Ramos C, Vega F, Medeiros LJ, Xu J. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22-31. e-Pub 2020. PMID: 33221344.
79. Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, You MJ, Lin P, Li S, Xu J, Han H, Bueso-Ramos CE, Medeiros LJ, Qiu X, Yin CC. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. Eur J Haematol 105(4):449-459, 2020. e-Pub 2020. PMID: 32535947.
80. Xie W, Xu J, Hu S, Li S, Wang W, Cameron Yin C, Toruner G, Tang Z, Jeffrey Medeiros L, Tang G. iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome. Mod Pathol 33(7):1389-1397, 2020. e-Pub 2020. PMID: 32034282.
81. Garces S, Yin CC, Miranda RN, Patel KP, Li S, Xu J, Thakral B, Poppiti RJ, Medina AM, Sriganeshan V, Castellano-Sánchez A, Khoury JD, Garces JC, Medeiros LJ. Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update. Mod Pathol 33(6):1104-1121, 2020. e-Pub 2020. PMID: 31896812.
82. Zhao S, Kanagal-Shamanna R, Navsaria L, Ok CY, Zhang S, Nomie K, Han G, Hao D, Hill HA, Jiang C, Yao Y, Nastoupil L, Westin J, Fayad L, Nair R, Steiner R, Ahmed S, Samaniego F, Iyer SP, Oriabure O, Chen W, Song X, Zhang J, Badillo M, Moghrabi O, Aranda J, Tang G, Yin CC, Patel K, Medeiros LJ, Li S, Vega F, Thirumurthi S, Xu G, Neelapu S, Flowers CR, Romaguera J, Fowler N, Wang L, Wang ML, Jain P. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol 95(6):623-629, 2020. e-Pub 2020. PMID: 32239765.
83. Xu J, Li S, Medeiros LJ. Reply to "PD-L1 expression in anaplastic large cell lymphoma". Mod Pathol 33(6):1234-1235, 2020. e-Pub 2020. PMID: 32203093.
84. Landsburg DJ, Ayers EC, Bond DA, Maddocks KJ, Karmali R, Behdad A, Curry M, Wagner-Johnston ND, Modi D, Ramchandren R, Assouline SE, Faramand R, Chavez JC, Torka P, Mier Hicks A, Medeiros LJ, Li S. Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy. Br J Haematol 189(2):313-317, 2020. e-Pub 2020. PMID: 31804715.
85. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma. Eur J Haematol 104(4):336-343, 2020. e-Pub 2020. PMID: 31944390.
86. Shen J, Medeiros LJ, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, Yin CC, Tang G, Jorgensen JL, Hu S, Miranda RN, Xu J. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma. Hum Pathol 98:1-9, 2020. e-Pub 2020. PMID: 32032618.
87. Jain P, Zhang S, Kanagal-Shamanna R, Ok CY, Nomie K, Gonzalez GN, Gonzalez-Pagan O, Hill HA, Lee HJ, Fayad L, Westin J, Nastoupil L, Hagemeister F, Chen W, Oriabure O, Badillo M, Jiang C, Yixin Y, Li S, Tang G, Yin CC, Patel KP, Medeiros LJ, Nair R, Ahmed S, Iyer SP, Thirumurthi S, Champlin R, Xu G, Tinsu P, Santos D, Wang R, Han G, Zhang J, Song X, Neelapu S, Romaguera J, Futreal A, Flowers C, Fowler N, Wang L, Wang ML. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv 4(6):1038-1050, 2020. e-Pub 2020. PMID: 32191807.
88. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol 33(3):324-333, 2020. e-Pub 2020. PMID: 31383967.
89. Xie W, Tang G, Li S, Yin CC, Xu J. Anaplastic multiple myeloma resembling dysplastic megakaryocytes. Clin Case Rep 8(3):568-569, 2020. e-Pub 2020. PMID: 32185061.
90. Torka P, Kothari SK, Sundaram S, Li S, Medeiros LJ, Ayers EC, Landsburg DJ, Bond DA, Maddocks KJ, Giri A, Hess B, Pham LQ, Advani R, Liu Y, Barta SK, Vose JM, Churnetski MC, Cohen JB, Burkart M, Karmali R, Zurko J, Mehta A, Olszewski AJ, Lee S, Hill BT, Burns TF, Lansigan F, Rabinovich E, Peace D, Groman A, Attwood K, Hernandez-Ilizaliturri FJ. Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics. Blood Adv 4(2):253-262, 2020. e-Pub 2020. PMID: 31945157.
91. Ayers EC, Li S, Medeiros LJ, Bond DA, Maddocks KJ, Torka P, Mier Hicks A, Curry M, Wagner-Johnston ND, Karmali R, Behdad A, Fakhri B, Kahl BS, Churnetski MC, Cohen JB, Reddy NM, Modi D, Ramchandren R, Howlett C, Leslie LA, Cytryn S, Diefenbach CS, Faramand R, Chavez JC, Olszewski AJ, Liu Y, Barta SK, Mukhija D, Hill BT, Ma H, Amengual JE, Nathan S, Assouline SE, Orellana-Noia VM, Portell CA, Chandar A, David KA, Giri A, Hess BT, Landsburg DJ. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer 126(2):293-303, 2020. e-Pub 2020. PMID: 31568564.
92. Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G. Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Leuk Lymphoma 60(12):1-9, 2019. e-Pub 2019. PMID: 31017498.
93. Bah I, Li S, Yin CC, Tang G, Xu J. Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma. Clin Case Rep 7(11):2256-2257, 2019. e-Pub 2019. PMID: 31788294.
94. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. e-Pub 2019. PMID: 31261288.
95. Shuai W, Li S. CD138- plasma cell myeloma. Blood 134(11):906, 2019. e-Pub 2019. PMID: 31515228.
96. Miao Y, Lin P, Saksena A, Xu J, Wang M, Romaguera J, Yin CC, Medeiros LJ, Li S. CD5-negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Patients. Am J Surg Pathol 43(8):1052-1060, 2019. e-Pub 2019. PMID: 31045891.
97. Chen Z, Sun Y, Xie W, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G. Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?. Cancer Med 8(9):4093-4099, 2019. e-Pub 2019. PMID: 31173486.
98. Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum Pathol 89:71-80, 2019. e-Pub 2019. PMID: 31054894.
99. Yuan J, Li S1, Liu X, Su RJ, Chen M, Wu X, Zheng G, Smith LM, Wang L, Li Y, Liu C, Zhou J, Shen Q, Zhang L, Wang E, Xu ML, Pan Z. Mantle Cell Lymphoma With Mantle Zone Growth Pattern. Am J Clin Pathol 152(2):132-145, 2019. e-Pub 2019. PMID: 31140550.
100. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136, 2019. e-Pub 2019. PMID: 31004601.
101. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Am J Surg Pathol 43(5):710-716, 2019. e-Pub 2019. PMID: 30768440.
102. Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P. Utility of JAK2 V617F allelic burden in distinguishing chronic Myelomonocytic leukemia from primary myelofibrosis with Monocytosis. Hum Pathol 85:290-298, 2019. e-Pub 2019. PMID: 30447300.
103. Zeng D, Desai A, Yan F, Gong T, Ye H, Ahmed M, Nomie K, Romaguera J, Champlin R, Li S, Wang M. Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma). Am J Clin Oncol 42(3):304-316, 2019. e-Pub 2019. PMID: 29419530.
104. Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z. t(3;8)(q26.2;q24) Often Leads to MECOM /MYC Rearrangement and is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. J Mol Diagn 21(2):343-351, 2019. e-Pub 2019. PMID: 30576868.
105. Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge. Am J Hematol. e-Pub 2019. PMID: 30916805.
106. Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang MI, Cohen JB, Calzada O, Churnetski MC, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Bast MA, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns TF, Donovan AM, Wagner-Johnston N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach AE, Landsburg DJ, Glenn M, Inwards DJ, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Fisher RI, Barta SK. Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era. J Clin Oncol 37(6):471-480, 2019. e-Pub 2019. PMID: 30615550.
107. Angelova EA, Li S, Wang W, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P. IgM plasma cell myeloma in the era of novel therapy: a Clinicopathologic study of 17 cases. Hum Pathol 84:321-334, 2019. e-Pub 2019. PMID: 30266252.
108. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ. Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 32(1):16-26, 2019. e-Pub 2019. PMID: 30323237.
109. Lyapichev K, Li S. Extensive Kaposi sarcoma infiltration in bone marrow in a patient with HIV. Blood 132(23):2525, 2018. e-Pub 2018. PMID: 30523127.
110. Jain P, Kanagal-Shamanna R, Zhang S, Ahmed M, Ghorab A, Zhang L, Ok CY, Li S, Hagemeister F, Zeng D, Gong T, Chen W, Badillo M, Nomie K, Fayad L, Medeiros LJ, Neelapu S, Fowler N, Romaguera J, Champlin R, Wang L, Wang ML. Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. Br J Haematol 183(4):578-587, 2018. e-Pub 2018. PMID: 30175400.
111. Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Cameron Yin C, Li S, Jeffrey Medeiros L, Tang G. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Ann Hematol 97(10):1775-1783, 2018. e-Pub 2018. PMID: 29872884.
112. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol 31(9):1470-1478, 2018. e-Pub 2018. PMID: 29785017.
113. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(76):34449, 2018. e-Pub 2018. PMID: 30344953.
114. Wang X, Cao X, Sun R, Tang C, Tzankov A, Zhang J, Manyam GC, Xiao M, Miao Y, Jabbar K, Tan X, Pang Y, Visco C, Xie Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, Winter JN, Piris MA, Li S, Miranda RN, Medeiros LJ, Li Y, Xu-Monette ZY, Young KH. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma. Neoplasia 20(6):574-593, 2018. e-Pub 2018. PMID: 29734016.
115. Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol 100(5):444-454, 2018. e-Pub 2018. PMID: 29385279.
116. Li S, Xu J. Plasma cell leukemia presenting as "lymphocytosis". Blood 131(17):1994, 2018. e-Pub 2018. PMID: 29699997.
117. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol 97(3):425-434, 2018. e-Pub 2018. PMID: 29285580.
118. Boddu PC, Wang SA, Pemmaraju N, Tang Z, Hu S, Li S, Xu J, Medeiros LJ, Tang G. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms. Leuk Res 66:73-78, 2018. e-Pub 2018. PMID: 29407586.
119. Xu J, Medeiros LJ, Saksena A, Wang M, Zhou J, Li J, Yin CC, Tang G, Wang L, Lin P, Li S. CD10-positive Mantle Cell Lymphoma: Clinicopathologic and Prognostic Study of 30 Cases. Oncotarget 9(14):11441-11450, 2018. e-Pub 2018. PMID: 29545910.
120. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 Expression in Mantle Cell Lymphoma Identifies a Unique Subgroup of Patients with Frequent IGHV Mutations, Absence of SOX11 Expression, and an Indolent Clinical Course. Mod Pathol 31(2):327-336, 2018. e-Pub 2018. PMID: 28984300.
121. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with t(4;12)(q12;p13): An aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(13):10987-10994, 2018. e-Pub 2018. PMID: 29541391.
122. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol 30(12):1688-1697, 2017. e-Pub 2017. PMID: 28776574.
123. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367-1377, 2017. e-Pub 2017. PMID: 28664935.
124. Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell 171(2):481-494.e15, 2017. e-Pub 2017. PMID: 28985567.
125. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica 102(9):1511-1518, 2017. e-Pub 2017. PMID: 28473622.
126. Guo Y, Strickland SA, Mohan S, Li S, Bosompem A, Vickers KC, Zhao S, Sheng Q, Kim AS. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia. Leuk Lymphoma 58(9):1-15, 2017. e-Pub 2017. PMID: 28084850.
127. Zhang L, Nomie K, Zhang H, Bell T, Pham L, Kadri S, Segal J, Li S, Zhou S, Santos D, Richard S, Sharma S, Chen W, Oriabure O, Liu Y, Huang S, Guo H, Chen Z, Tao W, Li C, Wang J, Fang B, Wang J, Li L, Badillo M, Ahmed M, Thirumurthi S, Huang SY, Shao Y, Lam L, Yi Q, Wang YL, Wang M. B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy. Clin Cancer Res 23(15):4212-4223, 2017. e-Pub 2017. PMID: 28348046.
128. Srour SA, Li S, Popat UR, Qazilbash MH, Lozano-Cerrada S, Maadani F, Alousi A, Kebriaei P, Anderlini P, Nieto Y, Jones R, Shpall E, Champlin RE, Hosing C. A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results. Br J Haematol 178(4):561-570, 2017. e-Pub 2017. PMID: 28485023.
129. Landsburg DJ, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Ilizaliturri F, Reddy NM, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Nathan S, Cassaday RD. Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission. J Clin Oncol 35(20):JCO2017722157, 2017. e-Pub 2017. PMID: 28475457.
130. Hu Z, Li S, Medeiros LJ, Sun T. TCL-1 Positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy. Hum Pathol 65:175-179, 2017. e-Pub 2017. PMID: 28232160.
131. Tang Z, Xu J, Wang SA, Li S, Young KH, Medeiros LJ, Tang G. Acquisition of t(2;18)(p11.2;q21.3) and NOTCH1 mutations during Richter’s transformation in chronic lymphocytic leukemia with t(14;19) (q32;q13) and trisomy 12. Transl Genet Genom. e-Pub 2017.
132. Pina-Oviedo S, Medeiros LJ, Li S, Khoury JD, Patel KP, Alayed K, Cason RC, Bowman CJ, Yin CC. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30(5):734-744, 2017. e-Pub 2017. PMID: 28084334.
133. Xu J, Li S. Triple-hit blastoid mantle cell lymphoma presenting like acute leukemia. Blood 129(18):2593, 2017. e-Pub 2017. PMID: 28473415.
134. Thakral B, Medeiros LJ, Desai P, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J, Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 98(4):415-421, 2017. e-Pub 2017. PMID: 28039906.
135. Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol 41(4):431-445, 2017. e-Pub 2017. PMID: 28248813.
136. Gur HD, Wang SA, Tang Z, Hu S, Li S, Medeiros LJ, Tang G. Clinical significance of isolated del(7p) in myeloid neoplasms. Leuk Res 55:18-22, 2017. e-Pub 2017. PMID: 28119224.
137. Zuo W, Wang SA, DiNardo C, Yabe M, Li S, Medeiros LJ, Tang G. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not MLL gene. J Clin Pathol 70(3):244-249, 2017. e-Pub 2017. PMID: 27496968.
138. Wang XJ, Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Mod Pathol 30(2):194-203, 2017. e-Pub 2017. PMID: 27739436.
139. Huang L, Wang SA, DiNardo C, Li S, Hu S, Xu J, Zhou W, Goswami M, Medeiros LJ, Tang G. Tetraploidy/Near-Tetraploidy Acute Myeloid Leukemia. Leuk Res 53:20-27, 2017. e-Pub 2017. PMID: 27951415.
140. Xu J, Oki Y, Saksena A, Desai P, Lin P, Tang G, Yin CC, You MJ, Thakral B, Medeiros LJ, Li S. CD30 Expression and Prognostic Significance in R-EPOCH Treated Patients with Diffuse Large B-Cell Lymphoma. Hum Pathol 60:160-166, 2017. e-Pub 2017. PMID: 27816715.
141. Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, Lu X, Pham LV, Young KH, Wang W, Hu S. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients. Am J Surg Pathol 41(2):216-224, 2017. e-Pub 2017. PMID: 27776009.
142. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol 41(1):82-93, 2017. e-Pub 2017. PMID: 27755009.
143. Xu J, Li S. Blasts with Abundant Cytoplasmic Granules: Acute Myeloid Leukemia or Granular Acute Lymphoblastic Leukemia?. Blood 129(4):537, 2017. e-Pub 2017. PMID: 28126958.
144. Sethi T, Nguyen V, Li S, Morgan D, Greer J, Reddy N. Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma Compared with Typical Nodular Sclerosis Hodgkin Lymphoma. Ther Adv Hematol 8(1):13-20, 2017. e-Pub 2017. PMID: 28042455.
145. Tang G, Bueso-Ramos CE, Li S, Medeiros LJ, Wang SA. Acquired 11q23/MLL Rearrangement of Unknown Clinical Significance. Int J Clin Exp Pathol 10(8):9048-9051, 2017. e-Pub 2017.
146. Miao Y, Hu S, Lu X, Li S, Wang W, Medeiros LJ, Lin P. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature. Hum Pathol 58:72-77, 2016. e-Pub 2016. PMID: 27544800.
147. Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. Br J Haematol 175(4):631-640, 2016. e-Pub 2016. PMID: 27469075.
148. Wang W, Chen Z, Hu Z, Yin CC, Li S, Bai S, Bueso-Ramos C, Medeiros LJ, Hu S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer. e-Pub 2016. PMID: 27813536.
149. Seegmiller AC, Kim AS, Mosse CA, Shaver AC, Thompson MA, Li S, Head DR, Zutter MM. Data-driven iterative refinement of bone marrow testing protocols leads to progressive improvement in cytogenetic and molecular test utilization. Am J Clin Pathol. e-Pub 2016. PMID: 27769956.
150. Tang Z, Li Y, Wang SA, Hu S, Li S, Lu X, Khoury JD, Medeiros LJ, Tang G. Clinical significance of acquired loss of the X chromosome in bone marrow. Leuk Res 47(47):103-113, 2016. e-Pub 2016. PMID: 27299973.
151. Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma. J Natl Compr Canc Netw 14(8):939-44, 2016. e-Pub 2016. PMID: 27496109.
152. Goswami RS, Wang SA, DiNardo C, Tang Z, Li Y, Zuo W, Hu S, Li S, Medeiros LJ, Tang G. Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms. Mod Pathol 29(7):727-34, 2016. e-Pub 2016. PMID: 27056073.
153. Wang XJ, Seegmiller AC, Reddy NM, Li S. CD30 Expression and Its Correlation with MYC Rearrangement in De Novo Diffuse Large B-Cell Lymphoma. Eur J Haematol 97(1):39-47, 2016. e-Pub 2016. PMID: 26340843.
154. Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, Galbincea J, Cason RC, Luthra R, Yin CC. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol 52:61-7, 2016. e-Pub 2016. PMID: 26980021.
155. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Histopathology 68(7):1090-8, 2016. e-Pub 2016. PMID: 26426741.
156. Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol 40(5):676-88, 2016. e-Pub 2016. PMID: 26872013.
157. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7:38122-38132. e-Pub 2016. PMID: 27203548.
158. Li Y, Hu S, Wang SA, Li S, Huh YO, Tang Z, Medeiros LJ, Tang G. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol 29(5):444-51, 2016. e-Pub 2016. PMID: 26916070.
159. Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, Eischen CM. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Hum Pathol 50:118-26, 2016. e-Pub 2016. PMID: 26997445.
160. Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol 50:109-17, 2016. e-Pub 2016. PMID: 26997444.
161. Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P. High-Grade B cell Lymphoma with MYC Rearrangement and without BCL2 and BCL6 Rearrangements Is Associated with High P53 Expression and a Poor Prognosis. Am J Surg Pathol 40(2):253-61, 2016. e-Pub 2016. PMID: 26448193.
162. Wang ML, Lee H, Chaung H, Wagner-Bartak N, Hagemeister F, Westin J, Fayad L, Samaniego F, Turturro F, Oki Y, Chen W, Badillo M, Nomie K, Rosa MD, Zhao DL, Lam L, Addison A, Zhang H, Young KH, Li S, Santos S, Medeiros LJ, Champlin R, Romaguera J, Zhang L. Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: A single-centre, open- label phase 2 trail. The Lancet Oncology 17(1):48-56, 2016. e-Pub 2016.
163. Khandakar B, Wang W, Li S. Primary splenic red pulp diffuse large B-cell lymphoma with anaplastic features. Stem Cell Investig 3:3-9, 2016. e-Pub 2016. PMID: 27358901.
164. Liu H, Li S. Mimics of Megakaryocytes: Giant Bizarre Myeloma Cells. Blood 2016 128(6):882, 2016. e-Pub 2016.
165. Liu H, Li S. Pediatric blastic plasmacytoid dendritic cell neoplasm, acute leukemic variant. Blood 126(25):2764, 2015. e-Pub 2015. PMID: 27064160.
166. Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol 90(10):882-7, 2015. e-Pub 2015. PMID: 26148174.
167. Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S. MYC Cytogenetic Status Correlates with Expression and Has Prognostic Significance in Patients with MYC/BCL2 Protein Double-Positive Diffuse Large B Cell Lymphoma. Am J Surg Pathol 39(9):1250-8, 2015. e-Pub 2015. PMID: 25828389.
168. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
169. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol 28(6):787-98, 2015. e-Pub 2015. PMID: 25743023.
170. Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. J Hematol Oncol 8(1):74, 2015. e-Pub 2015. PMID: 26104577.
171. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal Rearrangement Involving 11q23 Locus in Chronic Myelogenous Leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 1(8):32, 2015. e-Pub 2015. PMID: 25888368.
172. Tsai JP, Iams WT, Greer JP, Morgan DS, Li S, Reddy NM. Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma. Leuk Lymphoma 56(3):797-800, 2015. e-Pub 2015. PMID: 24884316.
173. Li S, Seegmiller AC, Lin P, Wang XJ, Miranda RN, Bhagavathi S, Medeiros LJ. B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas. Mod Pathol 28(2):208-17, 2015. e-Pub 2015. PMID: 25103070.
174. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood 124(15):2354-61, 2014. e-Pub 2014. PMID: 25161267.
175. Frank R, Li S, Ahmad NA, Sepulveda AR, Jhala NC. Mesothelin expression in pancreatic mucinous cysts. Am J Clin Pathol 142(3):313-9, 2014. e-Pub 2014. PMID: 25125620.
176. Douds JJ, Long DJ, Kim AS, Li S. Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma. J Clin Pathol 67(9):792-6, 2014. e-Pub 2014. PMID: 24958785.
177. Xu J, Li S. Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia. Case Rep Hematol 2014:304359, 2014. e-Pub 2014. PMID: 25057418.
178. Wang XJ, Kim A, Li S. Immunohistochemical analysis using a BRAF V600E mutation specific antibody is highly sensitive and specific for the diagnosis of hairy cell leukemia. Int J Clin Exp Pathol 7(7):4323-8, 2014. e-Pub 2014. PMID: 25120816.
179. Wang X, Lu X, Yin CC, Zhao L, Bueso-Ramos C, Medeiros LJ, Li S, Rogers J, His E, Lin P. Myeloid Neoplasms Associated with t(3;12)(q26.2;p13) Are Clinically Aggressive and Frequently Harbor FLT3 Mutations: A Report of 8 Cases and Review of Literature. J Leuk 3:161, 2014. e-Pub 2014.
180. Hooper K, Mukhtar F, Li S, Eltoum IA. Diagnostic error assessment and associated harm of endoscopic ultrasound-guided fine-needle aspiration of neuroendocrine neoplasms of the pancreas. Cancer Cytopathol 121(11):653-60, 2013. e-Pub 2013. PMID: 23839928.
181. Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ, Yin CC. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 37(1):14-23, 2013. e-Pub 2013. PMID: 23232851.
182. Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, Konoplev S, Medeiros LJ, Yin CC. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol 43(9):1436-43, 2012. e-Pub 2012. PMID: 22406370.
183. Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol 138(1):146-52, 2012. e-Pub 2012. PMID: 22706870.
184. Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25(1):145-56, 2012. e-Pub 2012. PMID: 22002575.
185. Li S, Wan M, Cao X, Ren Y. Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma. Arch Pathol Lab Med 135(7):903-8, 2011. e-Pub 2011. PMID: 21732781.
186. Li S, Yan Z, Jhala N, Jhala D. Fine needle aspiration diagnosis of Rosai-Dorfman disease in an osteolytic lesion of bone. Cytojournal 7:12, 2010. e-Pub 2010. PMID: 20806072.
187. Li S, Ai SZ, Owens C, Kulesza P. Intrapancreatic schwannoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration cytology. Diagn Cytopathol 37(2):132-5, 2009. e-Pub 2009. PMID: 19031416.
188. Li S, Faye-Petersen OM, Reilly SD. Intestinal obstruction in a term stillborn infant. Lab Medicine 39:410-412, 2008. e-Pub 2008.
189. Li S, Benjamin Jr W, Ho KJ. Fatal Strongyloides Hyperinfection Syndrome in a 66-Year Old Woman Receiving Steroid Therapy. Lab Medicine 39:29-32, 2008. e-Pub 2008.
190. Li S, Sato S, Yang X, Preisig PA, Alpern RJ. Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3. J Clin Invest 114(12):1782-9, 2004. e-Pub 2004. PMID: 15599403.
191. Li S, Zhu S, Wang H. The Polymorphism of Two Microsatellites - KG8 and CW2. J of Beijing Med Univ 30(3):213-215, 1998. e-Pub 1998.
192. Li S, Zhu S, Wang H. The Polymorphism of Two Microsatellites Closely Linked to the Locus for Polycystic Kidney Disease 1 in Chinese Population. Chinese J of Med Genet 15(6):360-363, 1998. e-Pub 1998.
193. Zhu S, Zhang H, Bai Q, Li S, Liu Y, Wang H. Gene Diagnosis of Chinese Families with Autosomal Dominant Polycystic Kidney Disease Using PCR Method. J of Beijing Mel Univ 28(6):419-421, 1996. e-Pub 1996.

Invited Articles

1. Qiu L, Medeiros LJ, Li S. High-grade B-cell lymphomas: Double hit and non-double hit. Hum Pathol 156:105700, 2024. e-Pub 2024. PMID: 39603365.
2. Garces, S, Xu, J, Li, S. Primary testicular follicular lymphoma. Human Pathology Reports 27, 2022. e-Pub 2022.
3. Kim, DH, Li, S, Garces, S, Xu, J. Large B-cell lymphoma with IRF4 rearrangement and follicular Pattern. Human Pathology Reports 27, 2022. e-Pub 2022.
4. Li S, Xu J, You MJ. The pathologic diagnosis of mantle cell lymphoma. Histol Histopathol 36(10):1037-1051, 2021. e-Pub 2021. PMID: 34114641.
5. Zuo Z, Li S, Xu J, You MJ, Khoury JD, Yin CC. Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing. Curr Hematol Malig Rep 14(5):376-385, 2019. e-Pub 2019. PMID: 31388824.
6. Li S, Lin P, Medeiros LJ. Advances in pathological understanding of high-grade B cell lymphomas. Expert Rev Hematol 11(8):637-648, 2018. e-Pub 2018. PMID: 29989509.
7. Li S, Young KH, Medeiros LJ. Diffuse large B cell lymphoma. Pathology 50(1):74-87, 2018. e-Pub 2018. PMID: 29167021.
8. Li S, Lin P, Bueso-Ramos C, Medeiros LJ. Advances in the Pathology of High Grade B Cell Lymphomas. Clin Lym Leu Mye 17(Suppl):S51-S53, 2017. e-Pub 2017.
9. Li S, Lin P, Young KH, Kanagal-Shamanna R, Yin CC, Medeiros LJ. MYC/BCL2 double-hit high-grade B-cell lymphoma. Adv Anat Pathol 20(5):315-26, 2013. e-Pub 2013. PMID: 23939148.

Review Articles

1. Xie W, Medeiros LJ, Fan G, Li S, Xu J. Systemic ALK-negative anaplastic large cell lymphoma: Insights into morphologic, immunophenotypic, genetic and molecular characteristics. Hum Pathol 156:105671, 2024. e-Pub 2024. PMID: 39424106.
2. Xie W, Medeiros LJ, Li S, Yin CC, Khoury JD, Xu J. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas. Curr Hematol Malig Rep 15(4):372-381, 2020. e-Pub 2020. PMID: 32394185.
3. Li S, Siegal GP. Small cell tumors of bone. Adv Anat Pathol 17(1):1-11, 2010. e-Pub 2010. PMID: 20032633.

Abstracts

1. Koff J, Russell V, Kositsky R, Jaye D, Churnetski M, Baird K, O'Leary C, Flowers C, Leppä S, Li S, Xu J, Pedersen M, Gang AO, Naresh KN, Au-Yeung R, Chapman J, Chadburn A, Lossos IS, Ondrejka S, Louissaint A, Tse E, Love C, Thakkar D, Parker C, Ong CK, Evans A, Mason EF, Jiong Y, Czader M, Evens A, Soliman D, Fedoriw Y, Dave S, Cohen J. Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status. Blood 146 (Supplement 1): 352, 2025. e-Pub 2025.
2. Li S. CD10 negative Burkitt lymphoma. 37th European Congress of Pathology, 2025.
3. Wei Q, Hu S, Xu J, Loghavi S, Toruner G, Li S, Medeiros L, Tang G. Chromoanagenesis: A Common Mechanism that Leads to Highly Complex Karyotypes, Clonal Heterogeneity and Therapeutic Resistance in Myelodysplastic Syndromes. Laboratory Investigation 105(3):1312, 2025. e-Pub 2025.
4. Loghavi S, Routbort M, Daver N, DiNardo C, Short N, Wang S, Wang W, Amin H, Jorgensen J, Xu J, Ok CY, Quesada A, Schlette E, Bueso-Ramos C, Fang H, Hu S, Li S, Lin P, Garces S, Tapan K, Issa G, Yilmaz M, Hammond D, Montalban-Bravo G, Jabbour E, Ravandi-Kashani F, Medeiros L, Patel K. FLT3 Internal Tandem Duplication Detection Using Ultrasensitive Error-Corrected NGS Improves Identification of Measurable Residual Acute Myeloid Leukemia. Laboratory Investigation 105(3):1251, 2025. e-Pub 2025.
5. Wang WJ, Hu S, Xu J, Quesada A, Loghavi S, Li S, Medeiros L, Tang G. The Value of Optical Genome Mapping in Diagnostically Challenging Cases of Low-Grade B-Cell Lymphoma. Laboratory Investigation 105(3):1308, 2025. e-Pub 2025.
6. Wei Q, Xu J, Hu S, Toruner G, Loghavi S, Li S, Wang W, Medeiros L, Tang G. KMT2A PTD Is Associated with Aberrant CD25 and CD123 Expression, FLT3 and DNMT3A Mutations, and Therapeutic Resistance in Myeloid Neoplasms. Laboratory Investigation 105(3):1310, 2025. e-Pub 2025.
7. Wei Q, Hu S, Loghavi S, Toruner G, Xu J, Li S, Medeiros L, Tang G. Utility of Optical Genome Mapping in Myelodysplastic Syndrome: Pros and Limitations. Laboratory Investigation 105(3):1311, 2025. e-Pub 2025.
8. Sridhar S, Hoppe MM, Jaynes P, Kumar G, Jasoria S, Meng Z, Peng Y, Mel SD, Poon L, Li Chan EH, Chng W, Tan SY, Hue SS, Ng S, Nagarajan C, Grigoropoulos NF, Li S, Khoury JD, Farinha P, Mottok A, Scott DW, Ye X, Pan-Hammarström Q, Rajan V, Kannan K, D Jeyasekharan AD. Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma. Blood 144(Suppl 1):3602, 2024. e-Pub 2024.
9. Loghavi S, Wang SA, Jen W, Wang W, Fang H, Li S, Garces SA, Quesada AE, Xu J, Ok CY, Hu S, Jorgensen JL, Tang G, Nasnas C, Karrar O, Issa GC, Daver N, DiNardo CD, Kadia TM, Kantarjian HM, Medeiros L, Ravandi F, Short NJ. Myeloid Progenitor Cells with Preleukemic Immunophenotypes Are Common in Myelodysplasia-Related and NPM1-mutated Acute Myeloid Leukemia and Should Not be Interpreted As Measurable Residual Disease. Blood 144(Suppl 1):4336, 2024. e-Pub 2024.
10. Shuyu E, Vega F, Khanlari M, Fang H, Xu J, Li S, Hu S, Wang S, Medeiros L, Wang W. BCL11B Helps to Define T-Lineage in Cases of Lymphoma/Leukemia with a Mixed or Ambiguous Phenotype. Lab Invest 104(3 Suppl):S1400-01, 2024. e-Pub 2024.
11. Rivera RS, Gonta R, Miranda R, Quesada A, Li S, Xu J, Vega F, L, Medeiros J, Lin P. Can Targeted Next Generation Sequencing Aid in Diagnosis and Subclassification of Marginal Zone Lymphoma Involving Bone Marrow?. Lab Invest 104(3 suppl):S1484, 2024. e-Pub 2024.
12. Wei Q, Toruner G, Hu S, Loghavi S, Li S, Xu J, Kanagal-Shamanna R, Jeffrey L, Medeiros, Tang G. Comprehensive Cytogenomic Profile of Adult Ph-negative B-lymphoblastic Leukemia by Optical Genome Mapping. Lab Invest 104(3 Suppl):S1500, 2024. e-Pub 2024.
13. Kim DH, Wang S, Wang W, Tang G, Li S, Yin C, Lin P, Konopleva M, M, You J, Wang X, Medeiros L, Xu J. Acute Myeloid Leukemia with Mast Cell Differentiation is Characterized by Interstitial Mast Cells, a Complex Karyotype, TP53 Alterations, and a Poor Prognosis. Lab Invest 104(3 Suppl):S1427-28, 2024. e-Pub 2024.
14. Sameeta F, Wang W, Jia F, Tang G, Li S, Xu J, Ok CY, Thakral B, Jeffrey L, Medeiros, Wang S. The Significance of Detecting Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes (MDS). Lab Invest 104(3 suppl):S1479, 2024. e-Pub 2024.
15. Nwogbo O, Li S, Miranda R, Vega F, Medeiros L, Ok CY. TP53-Mutated Mantle Cell Lymphoma shows Distinct Mutational Profiles from TP53-Wild Type Mantle Cell Lymphoma. Lab Invest 104(3 Suppl):S1462, 2024. e-Pub 2024.
16. Shuyu E, Medeiros L, Li S, Wang SA, Lin P, Wang W, Iyer SP, Malpica L, Yin C, Tang G, Tang Z, You M, Xu AJ. Low CD25 Expression is Associated with Older Age and Poorer Prognosis in Patients with ALK+ Anaplastic Large Cell Lymphoma. Lab Invest 103(3 Supplement):S1127, 2023. e-Pub 2023.
17. Nahmod KA, Tang Z, Lin P, Toruner GA, Li S, Xu J, Hu S, Medeiros L, Tang G. Cytogenetic Clonal Evolution in Plasma Cell Neoplasms. Lab Invest 103(3 Supplement):S1209, 2023. e-Pub 2023.
18. Younes S, Russell VS, Yin C, Li S, Xu J, Dave S. Elucidating the Genomic Landscape of Rosai-Dorfman Disease Using DNA and RNA Sequencing. Lab Invest 103(3 Supplement):S1230, 2023. e-Pub 2023.
19. Kim DH, Jelloul FZ, Loghavi S, Kanagal-Shamanna R, Yin C, Zuo Z, Patel KP, Routbort M, Li S, Vega F, Miranda RN, Medeiros L, Ok CY. Next-Generation Sequencing Identifies Approximately One Third of Mantle Cell Lymphoma Patients with Nuclear Factor-kappa B Pathway Mutations. Lab Invest 103(3 Supplement):S1168, 2023. e-Pub 2023.
20. Kim DH, Tang G, Lin P, Xu J, Wang S, Qiu L, Yin C, Wang W, Medeiros L, Li S. MYC and BCL6 Double Hit Lymphoma (DHL): A Clinicopathologic Study of 60 Cases in Comparison to BCL2-DHL and Diffuse Large B-cell Lymphoma (DLBCL). Lab Invest 103(3 Supplement):S1167, 2023. e-Pub 2023.
21. Nahmod KA, Wang SA, Li S, Tang Z, Aakash F, Xu J, Hu S, Medeiros L, Tang G. Immunophenotype and Cytogenetic Abnormalities in Plasma Cells of Lymphoplasmacytic Lymphoma and their Roles in Differential Diagnosis. Lab Invest 103(3 Supplement):S1209, 2023. e-Pub 2023.
22. Aakash F, Medeiros L, Qiu L, Xu J, Lin P, Miranda R, Thakral B, You M, Li S. Cases with Burkitt Lymphoma Morphology and an Atypical Immunophenotype or Complex Karyotype: Are They Burkitt Lymphoma?. Lab Invest 103(3 Supplement):S1082, 2023. e-Pub 2023.
23. Nirmalanantham P, Hu S, Li S, Xu J, Tang G, Lin P. Deletion of CDKN2C is Frequently Associated with Gains or Amplifications of CKS1B, Deletion of 13, Deletion of TP53 and a Complex Karyotype. Mod Pathol 103:S1213, 2023. e-Pub 2023.
24. Epperla N, Zayac A, Landsburg DJ, Hughes M, Bock AM, Nowakowski GS, Ayers EC, Girton M, Hu M, Beckman A, Li S, Medeiros L, Chang JE, Stepanovic A, Kurt H, Sandoval-Sus J, Ansari-Lari M, Kothari SK, Kress A, Xu ML, Torka P, Sundaram S, Smith SD, Naresh KN, Karimi Y, Bond DA, Farooq U, Saad M, Evens AM, Pandya K, Naik SG, Kamdar M, Haverkos BM, Karmali R, Oh TS, Vose JM, Nutsch H, Rubinstein P, Chaudhry A, Olszewski AJ. High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series. Blood 140(Supplement 1):3839-3841, 2022. e-Pub 2022.
25. Koff JL, Kositsky R, Jaye DL, Churnetski MC, Baird K, O'Leary CB, Flowers CR, Leppa S, Karjalainen-Lindsberg M, Li S, Xu J, Pedersen MØ, Gang AO, Naresh KN, Leeman-Neill RJ, Au Yeung KHR, Qureishi HN, Iqbal J, Chapman-Fredricks JR, McCall CM, Crump M, Chadburn A, Mulvey EC, Lossos IS, Ondrejka SL, Hsi ED, Louissaint A, Jr, Martin H, Tse E, Love C, Dave T, Parker C, Ong CK, Evans AG, Behdad A, Yang L, Reddy N, Arildsen MA, Juskevicius R, Yan J, Czader M, Evens AM, Soliman DS, Fedoriw Y, Dave SS, Cohen JB. Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma. Blood 140(Supplement 1):3500-3503, 2022. e-Pub 2022.
26. Qiu L, Khanlari M, Tang G, Xu J, Lin P, Khoury JD, Konoplev S, Garces S, Wang SA, Wang W, Medeiros L, Li S. Clinicopathologic and Cytogenetic Features of Blastoid High-grade B-cell Lymphoma. Mod Pathol 35(Suppl 2):1003-1004 (#931), 2022. e-Pub 2022.
27. Kim DH, Li S, Kanagal-Shamanna R, Miranda R, Vega F, Medeiros L, Ok CY. Next-generation Sequencing Revealed Frequent TP53 mutation in Mantle Cell Lymphoma with Enhancer of Zeste Homolog 2 (EZH2) Expression. Mod Pathol 35(Suppl 2):966-967 (#895), 2022. e-Pub 2022.
28. Nwogbo OV, hao S, Hu S, Li S, Xu J, Ramos C, Tang G, Medeiros LJ, Lin P. Prognostic Impact of 8q24/MYC Gene Rearrangement in Myeloma in the Era of Novel Therapy. Mod Pathol 35(Suppl 2):997 (#923), 2022. e-Pub 2022.
29. Fang H, Wang SA, Khoury JD, Kim DH, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Medeiros L, Wang W. Molecular and Immunophenotypic Features of Pure Erythroid Leukemia. Mod Pathol 35(Suppl 2):947 (#880), 2022. e-Pub 2022.
30. Qiu L, Tang G, Li S, Lin P, Wang SA, Konoplev S, Miranda RN, Iyer S, Wang W, Medeiros L, Xu AJ. DUSP22-Rearrangement is Associated with Younger Age, Unique Immunophenotype, and Minimal expression of PD-L1 and pSTAT3, but not Prognosis in Patients with Systemic ALK-Negative Anaplastic Large Cell Lymphoma. Mod Pathol 35(Suppl 2):1004 (#932), 2022. e-Pub 2022.
31. Wang M, Jain P, Lee HJ, Ok CY, Navsaria L, Kanagal-Shamanna R, Malpica-Castillo L, Nair L, Iyer SP, Samaniego F, Chen W, Oriabure O, Feng L, Thirumurthi S, Santos D, Tang G, Vega F, Li S, Avellaneda M, Badillo M, Flowers CR. Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma – Phase-II Window-2 Clinical Trial. Blood 138(Supplement 1), 2021. e-Pub 2021.
32. Jain P, Nomie K, Segodin V, Egorov E, Yao Y, Navsaria L, Hill H, Kotlov N, Kanagal-Shamanna R, Ok CY, Vega F, Li S, Che Y, Li Y, Svekolkin V, Bagaev A, Frenkel F, Attaulakhanov R, Fowler NH, Flowers CR, Wang M. Immune-Depleted Tumor Microenvironment Signature Is Associated with BTK Inhibitor Resistance in Mantle Cell Lymphoma. Blood 138(Supplement 1):1321, 2021. e-Pub 2021.
33. Love C, Pillai R, Ondrejka SL, Bhagat G, Chadburn A, McKinney M, Koff JL, Soliman DS, Czader M, Louissaint M, Li S, Ong CK, Behdad A, Evens AM, Natkunam Y, Norgaard PH, Leppa S, Tse E, Chapman JR, Amador C, Fedoriw Y, Bogusz AM, Evans AG, Goswami RS, Juskevicius R, Xu ML, Naresh KN, Xiong B, Snowden A, Thurman A, Smith E, Dave T, Kositsky R, Thakkar D, Russell V, Roth CJ, Dave S. The Atlas of Blood Cancer Genomes (ABCG) Project: A Comprehensive Molecular Characterization of Leukemias and Lymphomas. Blood 138(Supplement 1):2213, 2021. e-Pub 2021.
34. KHRA Y, Russell A, Choi W, Wong A, Tsui L, Lee YYC, Li J, Gill H, Ip HW, Kwong YL, Dave T, Ondrejka SL, Bhagat G, Chadburn A, Rutherford SC, Koff JL, Jaye DL, Czader M, Louissaint Jr A, Li S, Xu J, Yin CC, Ong CK, Cheng CL, Behdad A, Evens AM, Norgaard PH, Gang AO, Leppa S, Karjalainen-Lindsberg ML, Chapman JR, Amador C, Iqbal J, Fedoriw Y, Bogusz AM, Evans AG, Juskevicius R, Hsi ED, Naresh KN, Dave SS, Tse E. ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis. Blood 138(Supplement 1):2403, 2021. e-Pub 2021.
35. Zayac A, Landsburg DJ, Hughes M, Ayers EC, Girton M, Hu M, Beckman A, Li S, Medeiros LJ, Kurt H, Sandoval-Sus J, Ansari-Lari MA, Kothari SK, Kress A, Xu ML, Torka P, Sundaram S, Smith SD, Naresh KN, Karimi Y, Epperla N, Bond DA, Evens AM, Pandya K, Naik SG, Kamdar M, Haverkos B, Karmali R, Oh TS, Vose JM, Nutsch H, Rubinstein P, Chaudhry A, Olszewski AJ. High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Characteristics, Treatment, and Outcomes from 17 Academic US Centers. Blood 138(Supplement 1):455, 2021. e-Pub 2021.
36. Hoppe MM, Jaynes P, Fan S, Peng Y, Hoang PM, Liu X, De Mel S, Poon L, Chan E, Lee J, Chee YL, Ong CK, Tang T, Lim ST, Grigoropoulos NF, Tan SY, Hue SSS, Chang ST, Chuang SS, Li S, Khoury JD, Choi H, Farinha P, Mottok A, Scott DW, Wee-J C, Ng SB, Tripodo C, Jeyasekharan AD. MYC, BCL2 and BCL6 Coexpression Patterns at Single-Cell Resolution Re-Define Double Expressor Lymphomas. Hematological Oncology 39(S2). e-Pub 2021.
37. Karmali R, Donovan A, Wagner-Johntson N, Messmer M, Mehta A, Anderson J, Reddy N, Kovach A, Landsburg D, Glenn M, Inwards D, Ristow K, Lansigan F, Kaplan J, Caimi P, Rajguru S, Evens A, Klein A, Umyarova E, Amengual J, Lue J, Diefenbach C, Epperla N, Barta S, Hernandez-Ilizaliturri F, Handorf E, Villa D, Gerrie A, Mederios S, Wang M, Cohen J, Calzada O, Churnetski M, Hill B, Sawalha Y, Gerson J, Kothari S, Vose J, Bast M, Fenske T, Gari S, Maddocks K, Bond D, Bachanova V, Kolla B, Chavez J, Shah B. Survival following First Relapse in Younger Patients with Mantle Cell Lymphoma. Hematological Oncology 39(S2):217, 2021. e-Pub 2021.
38. Jelloul FZ, Yang RK, Li S, Tang G, Patel K, Meddeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Myeloma Patients in The Era of Novel Therapies: A Study of 60 Patients. Mod Pathol 34(Suppl 2):847 (#705), 2021. e-Pub 2021.
39. Qiu L, Khanlari M, Li S, Tang G, Yin CC, Wang SA, Iyer S, You MJ, Konoplev SN, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is Characterized by Thrombocytopenia, Bone Marrow Involvement, CD7 Positivity, Complex Karyotype, and a Poor Prognosis. Mod Pathol 34(Suppl 2):883 (#731), 2021. e-Pub 2021.
40. Khanlari M, Lin P, Xu J, You MJ, Tang G, Yin CC, Qiu L, Bueso-Ramos C, Medeiros LJ, Li S. Blastoid B-cell Lymphoma Initially Presenting in Bone Marrow: A Diagnostic Challenge. Mod Pathol 34(Suppl 2):865 (#718), 2021. e-Pub 2021.
41. Jain P, Tang G, Yin CC, Ok CY, Navsaria L, Badillo M, Chen W, Li Y, Che Y, Liu Y, Oriabure O, González GMN, Westin J, Nastoupil LJ, Ahmed S, Nair R, Thirumurthi S, Li S, Kanagal-Shamanna R, Vega F, Flowers CR, Wang M. Complex Karyotype Is a Significant Predictor for Worst Outcomes in Patients with Mantle Cell Lymphoma (MCL) Treated with BTK Inhibitors – Comprehensive Analysis of 396 Patients. Blood 136(Supplement 1):32-33, 2020. e-Pub 2020.
42. Jain P, Yao Y, Zhao S, Liu Y, Hill H, Che Y, Li Y, Jordan AA, McIntosh J, Lee HJ, Steiner RE, Samaniego F, Westin J, Nastoupil LJ, Nair R, Ahmed S, OK CY, Kanagal-Shamanna R, Oriabure O, Xu G, Chen W, Moghrabi O, McClain CM, Badillo M, Thirumurthi S, Santos D, Iliescu C, Yin CC, Li S, Tang G, Vega F, Neelapu SS, Flowers CR, Wang L, Wang M. Combination of ibrutinib with rituximab (IR) in previously untreated elderly patients with mantle cell lymphoma (MCL) – a phase II clinical trial. Blood 136(Suppl 1):41-42, 2020. e-Pub 2020.
43. Jain P, Kanagal-Shamanna R, Navsaria L, Ok CY, Hill H, Jung D, González GMN, Lee HJ, Nair R, Ahmed S, Steiner RE, Tang G, Li S, Patel K, Thirumurthi S, Tinsu P, Xu G, Vega F, Flowers CR, Wang M. Comprehensive analysis of factors predictive for time to transformation and risk of transformation in patients (pts) with mantle cell lymphoma. Blood 136(Supplement 1):41-42, 2020. e-Pub 2020.
44. El Hussein S, Medeiros LJ, Lyapichev K, Gruschkus SK, Wei P, Schlette E, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Patel KP, Bhalla KN, Khoury JD. Immune Evasion Phenotype is Common in Richter Transformation Diffuse Large B-Cell Lymphoma and Correlates with CD30 Expression. Blood 136(Supplement 1):19-20, 2020. e-Pub 2020.
45. Jain P, Yao Y, Zhao S, Liu Y, Hill H, Che Y, Li Y, Jordan AA, McIntosh J, Lee HJ, Steiner RE, Samaniego F, Westin J, Nastoupil LJ, Nair R, Ahmed S, Ok CY, Kanagal-Shamanna R, Oriabure O, Xu G, Chen W, Moghrabi O, McClain CM, Badillo M, Thirumurthi S, Santos D, Iliescu S, Yin CC, Li S, Tang G, Vega F, Neelapu SS, Flowers CR, Wang L, Wang M. Outcomes of acalabrutinib failures in relapsed mantle cell lymphoma. Blood 136(Supplement 1):9-10, 2020. e-Pub 2020.
46. Khanlari M, Li S, Medeiros LJ, Iyer S, Yin CC, Lin P, Tang G, Konoplev SN, Miranda RN, Xu J. Small Cell/Lymphohistiocytic Morphology Is Associated with CD8 Positivity, Retained T Cell Markers, A Trend of Decreased PD-L1 Expression, but Not Outcome in Adults with ALK + ALCL. Journal for ImmunoTherapy of Cancer 8(Suppl 3):A51, 2020. e-Pub 2020.
47. Lyapichev K, Medeiros LJ, Li S, Yin CC, Tang G, You MJ, Konoplev SN, Iyer S, Bueso-Ramos C, Miranda RN, Xu J. MYC Expression in Systemic Anaplastic Large Cell Lymphoma: Clinicopathologic and Prognostic Features of 70 Patients 134(Suppl 1):1560, 2019. e-Pub 2019.
48. Li X, Kositsky R, Reddy A, Love C, Naresh K, Koff JL, Nystrand I, Leppä S, Pasanen A, Karjalainen-Lindsberg ML, Dunkel J, Kovanen P, Qin Q, Bhagat G, Leeman-Neill RJ, Goswami RS, Wildeman S, Delabie J, Burack R, Evans AG, Amador C, Yuan J, Qureishi HN, Li S, Xu J, Yin CC, Gang AO, Norgaard PH, MØ P, Chan JY, Cheah DMZ, Ong SY, Cheng CL, Lee L, Paulua F, Ondrejka SL, Hsi ED, Czader M, Wang L, Landis A, Churnetski MC, Jaye DL, Flowers CR, McCall CM, Neff J, McKinney MS, Fedoriw Y, Powers E, Montgomery ND, Bogusz AM, Stafford Hintz A, Kovach AE, Reddy N, Thompson Arildsen MA, Mason EF, Juskevicius R, Choi W, Au-Yeung R, Tse E, Sarno V, Chadburn A, Lopez R, Chapman JR, Behdad A, Goldschmidt N, Goodlad J, Burton C, Pillai R, Louissaint A, Soliman DS, Panea R, Dave T, Xiong B, Smith E, Dave S. Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma. Blood 134(Suppl 1):19, 2019. e-Pub 2019. PMID: 31723982.
49. Jain P, Kanagal-Shamanna R, Ok CY, Omarya G, Navsaria L, González GMN, Zhang S, Han G, Ghorab A, Boddu P, Hagemeister FB, Lee HJ, Nomie K, Jiang C, Fayad L, Westin J, Nastoupil LJ, Ahmed S, Iyer SP, Champlin RE, Neelapu SS, Romaguera JE, Fowler NH, Tang G, Li S, Patel K, Thirumurthi S, Tinsu P, Xu G, Wang L, Wang M. Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma – Cohort Study of 369 Patients. ASH 134(Suppl 1):1526. e-Pub 2019.
50. Shen J, Li S, Yin CC, Wang SA, Lin P, Jorgensen JL, Tang G, Hu S, Medeiros LJ, Xu J. CD8 Expression in Anaplastic Large Cell Lymphoma Identifies a Subgroup with Advanced Stage, Non-common Morphology, Unique Phenotype, and Poorer Outcome. Mod Pathol 32(Suppl 2):138 (#1387), 2019. e-Pub 2019.
51. Xie W, Wang SA, Chen Z, Li S, Miranda RN, Hu S, Medeiros LJ, Tang G. Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms Followed by Acute Lymphoblastic Leukemia. Mod Pathol 32(Suppl 2):167 (#1421), 2019. e-Pub 2019.
52. Garces S, Piubelli MLM, Siquiera SAC, Sriganeshan V, Medina AM, Castellano-Sanchez A, Poppiti R, Khoury JD, Li S, Xu J, Saluja K, Bhattacharjee MB, Medeiros LJ, Yin CC. Cyclin D1 protein is overexpressed in Rosai-Dorfman disease. Mod Pathol 32(Suppl 2):52 (#1290), 2019. e-Pub 2019.
53. Chen Z, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G. Is Hyperdiploidy Favorable in Adult B-Lymphoblastic Leukemia?. Mod Pathol 32(Suppl 2):23 (#1259), 2019. e-Pub 2019.
54. Hao S, Konoplev S, Lu X, Li S, Hu S, Xu J, Tang G, Medeiros LJ, Lin P. The Survival Impact of 1q+/CKSB1 Depends on Background Karyotype and Del(17p)/TP53 Allelic Burden. Mod Pathol 32(Suppl 2):62 (#1300), 2019. e-Pub 2019.
55. Xu J, Wang S Wang L, Tang G, Lin P, Yin CC, Medeiros LJ, Li S. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma. Mod Pathol 32(Suppl 2):168 (#1423), 2019. e-Pub 2019.
56. Ayers EC, Li S, Medeiros LJ, Bond DA, Maddocks KJ, Torka P, Hicks AM, Curry M, Wagner-Johnston ND, Karmali R, Behdad A, Fakhri B, Kahl BS, Churnetski MC, Cohen JB, Reddy N, Modi D, Ramchandren R, Howlett C, Leslie LA, Cytryn S, Diefenbach C, Faramand R, Chavez JC, Olszewski AJ, Liu Y, Barta SK, Mukhija D, Hill BT, Ma H, Amengual JE, Nathan S, Assouline S, Orellana-Noia VM, Portell CA, Chandar A, David KA, Giri A, Hess BT, Landsburg DJ. Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy. Blood 2018 132:453; doi: https://doi.org/10.1182/blood-2018-99-115527, 2018. e-Pub 2018.
57. Kothari SK, Li S Medeiros LJ, Ayers EC, Landsburg DJ, MD, Bond DA, Maddocks KJ, Giri A, Hess BT, MD, Pham LQ, Advani R, Liu Y, MD, Barta SK, Vose JM, Churnetski MC, Cohen JB, Burkart M, Karmali R, Zurko J, Mehta A, Olszewski AJ, Lee SS, Hill BT, Burns TF, Lansigan F, Rabinovich E, Peace D, Groman A, Attwood K, Hernandez-Ilizaliturri FJ, Torka P. Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers. Blood 2018 132:451; doi: https://doi.org/10.1182/blood-2018-99-111530, 2018. e-Pub 2018.
58. Garces S, Huang W, Li S, Lin P. Clinicopathologic and Immunophenotypic Features of MYD88 L265P-positive Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia (LPL/WM): A Study of 30 Cases. Mod Pathol, 2018. e-Pub 2018.
59. Shen J, Li S, Yin CC, Wang S, Lin P, Jorgensen J, Tang G, Hu S, Medeiros LJ, Xu J. CD8 Expression in Anaplastic Large Cell Lymphoma Identifies a Subgroup with Advanced Stage, Non-common Morphology, Unique Phenotype, and Poorer Outcome. Mod Pathol, 2018. e-Pub 2018.
60. Xu J, Saksena A, Wang L, Yin CC, Wang SA, Hu Z, Lin P, Tang G, Medeiros LJ, Li S. Characterization of SOX11-Negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 53 Patients. Mod Pathol, 2018. e-Pub 2018.
61. Liu JL, Medeiros LJ, Huang W, McDonnell T, Miranda RN, Bueso-Ramos CE, Schlette E, Lin P, Li S. MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP. Mod Pathol, 2018. e-Pub 2018.
62. Wang L, Lin P, Xu J, Pan Z, Yin CC, Loghavi S, Khoury JD, Medeiros LJ, Li S. CD5-Negative and CD10-Positive Mantle Cell Lymphoma: A Clinicopathologic Study of 10 Cases. Mod Pathol, 2018. e-Pub 2018.
63. He J, Lu X, Li S, Hu S, Wang W, Yin CC, Lin P. Multiple myeloma with t(14;16) MAF-IGH is associated with other high risk Genetic features. Mod Pathol 31(Suppl 2), 2018. e-Pub 2018.
64. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xue J, Medeiros LJ. Rosai-Dorfman disease co-existing with lymphoma in the same lymph node: a localized histiocytic proliferation with MAPK/ERK pathway-induced cyclin D1 upregulation, 2018. e-Pub 2018.
65. Gerson JN, Barta SK, Villa D, Gerrie AS, Li S, Medeiros LJ, Wang M, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose JM, Fenske TS, Rao SN, Maddocks KJ, Bond DA, Lansigan F, Burns T, Donovan AM, Mehta A, Reddy N, Landsburg DJ, Glenn M, Inwards DJ, Ristow K, Karmali R, Kaplan J, Umyarova E, Pulluri B, Amengual JE, Lue JK, Caimi P, Cohen JB, Calzada O, Handorf E, Anderson JK, Chapani P, Bachanova V, Rajguru S, Churnetski MC, Diefenbach C, Bast M, Kovach AE. Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era. Blood 130(Suppl. 1):341, 2017. e-Pub 2017.
66. Zhang J, Reddy A, Davis N, Moffitt A, Love C, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg M, Norgaas PH, Pedersen M, Gang AO, Høgdall E, Heavican T, Lone W, Iqbal J, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton A, Flowers C, Paltiel-Clarfield L, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader M, Ondrejka SL, Collie A, Hsi EA, Tse E, Au-Yeung R, Kwong YL, Srivastava G, Choi W, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Rempel R, Tzeng T, Dave T, Rajagopalan D, Datta J, Dunson D, Dave S. Integrative Analysis of 1001 Diffuse Large B Cell Lymphoma Identifies Novel Oncogenic Roles for Rhoa. Blood 130(Suppl. 1):37, 2017. e-Pub 2017.
67. Wang ML, Lee H, Thirumurthi S, Chuang H, Hagemeister F, Westin J, Fayad L, Samaniego F, Turturro F, Chen W, Oriabure O, Feng L, Zhou S, Huang S, Li S, Zhang L, Badillo M, Wu L, Ahmed, Yan F, Nomie K, Lam L, Addison A, Romaguera J. IBRUTINIB‐RITUXIMAB FOLLOWED BYREDUCED CHEMO‐IMMUNOTHERAPYCONSOLIDATION IN YOUNG, NEWLYDIAGNOSED MANTLE CELL LYMPHOMAPATIENTS: A WINDOW OF OPPORTUNITYTO REDUCE CHEMO. Hematological Oncology 35(S2):142-143, 2017. e-Pub 2017.
68. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Khoury J, Yin C. Recurrent KRAS and MAP2K1 Mutations Detected in Rosai- Dorfman Disease by Next-Generation Sequencing. Mod Pathol 30(2 Suppl):349A, 2017. e-Pub 2017.
69. Xu J, Saksena A, Zhou J, Li J, Yin C, Tang G, Medeiros LJ, Li S. CD10-Positive Mantle Cell Lymphoma: Clinicopathologic and Prognostic Study of 28 Cases. Mod Pathol 30(2 suppl):387A, 2017. e-Pub 2017.
70. Angelova EA, Lu X, Li S, Medeiros LJ, Lin P. IgM Multiple Myeloma in the Era of Novel Therapy: Clinicopathologic Study of 14 Cases. Mod Pathol 30(2 Suppl):337A, 2017. e-Pub 2017.
71. Saksena A, Li J, Yin C, Wang M, Lin P, Zhou J, Miranda RN, Medeiros LJ, Li S. CD23+ Mantle Cell Lymphoma: A Clinicopathologic Analysis of 59 Cases. Mod Pathol 30(2 Suppl):374A, 2017. e-Pub 2017.
72. Gur D, Loghavi S, Routbort MJ, Garcia-Manero G, Yin C, Li S, Medeiros LJ, Khoury JD. JAK2 p.V617F Mutations Are Common in Chronic Myelomonocytic Leukemia with Fibrosis. Mod Pathol 30(2 Suppl):353A, 2017. e-Pub 2017.
73. Li S, Huang W, Oki Y, Medeiros LJ. MYC/BCL2/BCL6 triple hit lymphoma: A study of 33 patients who had an aggressive clinical course similar to patients with double hit lymphomas. Journal of Clinical Oncology 35(15_suppl):7559, 2017. e-Pub 2017.
74. Li S, Xu J, Hu S, Wang W, Konoplev S, Medeiros LJ, Ramos CE, Yin CC. Chronic myelogenous leukemia in myeloid blast phase with inv(16)(p13.1q22)/CBFB-MYH11. e-Pub 2017.
75. Li S, Tang G, Wang SA, Konoplev S, Yin CC, Xu J, Medeiros LJ, Lin P. B-Lymphoblastic Leukemia with CRLF2 Rearrangement and JAK2 Mutation. e-Pub 2017.
76. Li N, Li S, Zuo Z, Li J, Young KH, Medeiros LJ, Bueso-Ramos CE, Yin CC. Preleukemic chronic myelogenous leukemia. e-Pub 2017.
77. Tang G, Wang S, Li S, Medeiros LJ, Muzzafar T. Incidental (Early Stage?) Chronic Myeloid Leukemia Diagnosed in a Patient Presented With Lymphocytosis and Lymphadenopathy. e-Pub 2017.
78. Li J, Li S, Xu J, Li N, Jorgensen JL, Lin P, Bueso-Ramos CE, Medeiros LJ, Yin CC. Philadelphia chromosome-positive acute leukemia with early T-cell precursor immunophenotype. e-Pub 2017.
79. Xu J, Tang Z, Wang S, Li S, Medeiros LJ, Tang G. Diffuse Large B Cell Lymphoma Arising from Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Concurrent BCL3 and BCL2 Rearrangements. e-Pub 2017.
80. Yin CC, Patel KP, Zuo Z, Wang SA, Li S, Medeiros LJ, Bueso-Ramos CE. Novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. e-Pub 2017.
81. Hu Z, Konoplev S, Li S, Yin CC Hidalgo Lopez PJ, Bueso-Ramos CE, Lin P. Primary Myelofibrosis Presenting With Marked Monocytosis Mimicking Chronic Myelomonocytic Leukemia at Initial Presentation. e-Pub 2017.
82. Li S, Xu J, Yin CC, Khoury J, Medeiros LJ, Bueso-Ramos C, Lin P. Refractory Myelodysplastic Syndrome with JAK2 Mutation. e-Pub 2017.
83. Xu J, Medeiros LJ, Yin CC, Tang G, Lin P, Li S. Triple-hit Blastoid Mantle Cell Lymphoma Presenting like Acute Leukemia. e-Pub 2017.
84. Yin CC, Khoury JD, Xu J, Lin P, You J, Muzzafar T, Bueso-Ramos CE, Medeiros LJ, Li S. Acute myeloid leukemia with clonal evolution upon progression. e-Pub 2017.
85. Wang M, Lee HL, Thirumurthi S, Chuang HH, Hagemeister FB, Westin JR, Fayad LE, Samaniego F, Turturro F, Chen W, Oriabure O, Huang SY, Li S, Zhang L, Badillo M, Hartig KH, Ahmed M, Nomie K, Lam LT, Addison AA, Romaguera JE. Chemotherapy-Free Induction with Ibrutinib-Rituximab Followed By Shortened Cycles of Chemo-Immunotherapy Consolidation in Young, Newly Diagnosed Mantle Cell Lymphoma Patients: A Phase II Clinical Trial. Blood 128(22):147, 2016. e-Pub 2016.
86. Quesada AE, Desai PA, Tang G, Lin P, Westin JR, Seegmiller A, Wei P, Yin CC, Wang W, Xu J, Miranda R, Reddy N, Medeiros LJ, Li S. MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma. Blood 128(22):154, 2016. e-Pub 2016.
87. Saksena A, Miao Y, Lin P, Wang M, Yin CC, Li J, Medeiros LJ, Li S. CD5 Negative Mantle Cell Lymphoma: Clinicopathologic Correlations and Outcome in 58 Cases. Blood 128(22):2964, 2016. e-Pub 2016.
88. Zhang J, Reddy A, Love C, Moffitt A, Rajagopalan A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg M, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Richards K, Fedoriw Y, Bernal-Mizrachi L, Koff J, Staton A, Flowers C, Ora P, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader M, Ondrejka S, Collie A, His E, Au-Yeung RKH, Kwong YL, Choi WWL, Srivastava G, Evens A, Pilichowska M, Sengar M, Reddy N, Li S, Gordon L, Jaffe E, Tzeng T, Datta J, Dunson D, Dave S. Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups. Blood 128(22):1287, 2016. e-Pub 2016.
89. Landsburg DJ, Reddy NM, Falkiewicz MK, Maly J, Blum KA, Howlett C, Feldman T, Mato AR, Hill BT, Li S, Medeiros LJ, Torka P, Hernandez-Iliazliturri F, Singavi A, Fenske TS, Chavez JC, Kaplan JB, Behdad A, Petrich AM, Bast MA, Vose JM, Olszewski AJ, Costa C, Lansigan F, Gerson JN, Barta SK, Calzada O, Cohen JB, Lue JK, Amengual JE, Rivera X, Persky DO, Peace DJ, Cassaday RD. Benefit of Consolidative Autologous Stem Cell Transplantation in First Complete Remission for Patients with Double Hit Lymphoma Appears Dependent on Induction Regimen Intensity. Blood 128(22):3455, 2016. e-Pub 2016.
90. Xu J, Tang G, Medeiros, LJ, Li S. B cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma in a patient with a history of Burkitt lymphoma, 2016. e-Pub 2016.
91. Wang W, Loghavi S, Robinson M, Lu X, Li S, Medeiros LJ. Diffuse large B cell lymphoma with aggressive histologic features and MYC gene rearrangement, 2016. e-Pub 2016.
92. Hu Z, Miranda R, Caraway N, Katz R, Li S, Patel K, Oki Y, Lin P. CD5+ low grade B-cell lymphoma with CNS and extranodal involvement, 2016. e-Pub 2016.
93. Yin CC, Li S, Hu S, Zuo Z, Lin P, Konoplev S, KHoury JD, Young KH, Medeiros LJ, Li Y. CD5-positive follicular lymphoma with large cell transformation, 2016. e-Pub 2016.
94. Yin CC, Li S, Xu J, Lin P, Medeiros LJ, Abruzzo LV. Mantle cell lymphoma, blastoid variant, arising from classical mantle cell lymphoma, 2016. e-Pub 2016.
95. Li Y, Hu S, Wang S, Huh YO, Li S, Medeiros J, Tang G. MYC Rearrangement in Chronic Lymphocytic Leukemia, Is Not Often Associated with Poor Prognosis. Mod Pathol 29, 2016. e-Pub 2016.
96. Pina-Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans Cell Histiocytosis in Patients with Concurrent Lymphoma: A Reactive Process without Evidence of BRAF Mutation. Mod Pathol 29, 2016. e-Pub 2016.
97. Hu Z, Wang W, Chen Z, Tang G, Lu X, Li S, Medeiros LJ, Hu S. Mantle Cell Lymphoma with MYC Rearrangement: Best Considered as a Form of Double Hit Lymphoma?. Mod Pathol 29, 2016. e-Pub 2016.
98. Xu J, Saksena A, Desai P, Lin P, Yin CC, Tang G, You MJ, Medeiros LJ, Li S. CD30 Expression and Its Prognostic Significance in De Novo Diffuse Large B Cell Lymphoma Treated with Rituximab-EPOCH. Mod Pathol 29, 2016. e-Pub 2016.
99. Liu W, Li S, Lu G, Lu X, Ji Y, Chen Z, Medeiros J, Hu S. Prognostic Importance of MYC Deletion Detected by Fluorescence In Situ Hybridization in Paraffin Sections in Diffuse Large B-cell Lymphoma. Mod Pathol 29, 2016. e-Pub 2016.
100. Yabe M, Medeiros LJ, Tang G, Wang S, Bhagat G, Kanagal-Shamanna R, Bueso-Ramos C, Jorgensen JL, Chen W, Hoehm D, Lu G, Li S, Young KH, Miranda R. Prognostic factors of hepatosplenic T-cell lymphoma (HSTCL): A clinicopathologic, immunophenotypic, and cytogenetic analysis of 28 patients. Mod Pathol 29, 2016. e-Pub 2016.
101. Thakral B, Desai P, Lin P, Yin CC, Tang G, Hu S, Khoury JD, Medeiros LJ, Li S. Prognostic Significance of CD5 Expression in Diffuse Large B-cell Lymphoma in Patients Treated with Rituximab-EPOCH 29, 2016. e-Pub 2016.
102. Pina Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans cell histiocytosis in patients with concurrent lymphoma, 2016. e-Pub 2016.
103. Yabe M, Medeiros LJ, Tang G, Wang S, Konoplev S, Bhagat G, Jabbar K, Bueso-Ramos C, Loghavi S, Hoehm D, Lu G, Li S, Young KH, Miranda R. Evaluation of myelodysplastic features and correlation with cytogenetic findings in hepatosplenic T-cell lymphoma: analysis of 28 patients. Mod Pathol 28:389A, 2015. e-Pub 2015.
104. Sethi TK, Nguyen VT, Li S, Morgan DS, Greer JP, Reddy NM. Differences in Outcome of Patients with Syncytial Variant Hodgkin Lymphoma (HL) Compared with Typical Nodular Sclerosis HL. Blood 126:1441, 2015. e-Pub 2015.
105. Wang XJ, Reddy NM, Medeiros LJ, Li S. P53 Protein Expression Correlates with Inferior Survival in Patients with Diffuse Large B-cell Lymphoma (DLBCL) overall and also is Prognostic in DLBCL with MYC Rearrangement or Concurrent MYC/BCL2 Expression. Mod Pathol 28(Suppl 2):385A, 2015. e-Pub 2015.
106. Shen Q, Li S, Chen M, Song J, Lu G, Tang G, Hu S, Wang X, Lin P, Medeiros LJ, Yin CC. Acute myeloid leukemia/myelodysplastic syndrome with t(3;5): Clinicopathologic, immunophenotypic, and molecular genetic features of 16 cases. Mod Pathol 28(Suppl. 2):377A, 2015. e-Pub 2015.
107. Saksena A, Desai P, Xu J, Zuo Z, Lin P, Yin CC, Seegmiller A, Jorgensen JL, Miranda R, Reddy N, Bueso-Ramos CE, Medeiros LJ, Li S. MYC/BCL2 Double Hit Lymphoma: What Really Matters 126:3909, 2015. e-Pub 2015.
108. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol 28(Suppl. 2):359A, 2015. e-Pub 2015.
109. Wang XJ, Seegmiller AC, Reddy NM, Li S. The Prognostic Significance of CD30 Expression and Its Correlation with MYC Rearrangement in De Novo Diffuse Large B-Cell Lymphoma. Mod Pathol 28(Suppl 2):385A, 2015. e-Pub 2015.
110. Wang X, Li S. Immunohistochemical Analysis Using a BRAF V600E Mutation Specific Antibody is Highly Sensitive and Specific for the Diagnosis of Hairy Cell Leukemia. Mod Pathol 27(Suppl. 2):384A (1575), 2014. e-Pub 2014.
111. Weiss V, Wang X, Medeiros LJ, Reddy N, Li S. Large B-cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma. Mod Pathol 27(Suppl. 2):385A (1580), 2014. e-Pub 2014.
112. Wang X, Medeiros LJ, Arildsen MAT, Lin P, Yin CC, Abel T, Li S. MYC/BCL2 Double-Hit (DHL) and MYC aberrations correlate with a Worse Outcome within MCY/BCL2 Protein Double-Positive (DPL) High-Grade B Cell Lymphoma. Mod Pathol 27(Suppl. 2):384A (1578), 2014. e-Pub 2014.
113. Wang X, Reddy N, Li S. MYC gene single hit diffuse large B cell lymphoma behaves similarly to MYC/BCL2 double hit lymphoma and needs similar aggressive treatment. Blood 122(no. 21):4313, 2013. e-Pub 2013.
114. Tsai J, Greer JP, Morgan DS, Li S, Reddy N. Role of aggressive chemotherapeutic regimens in double hit lymphoma- can alternate aggressive induction regimens overcome the poor prognosis of diffuse large B cell lymphoma?. Blood 122(no. 21):4361, 2013. e-Pub 2013.
115. Seegmiller AC, Kim AS, Mosse CA, Thompson MA, Li S, Shaver A, Zutter M. Data-Driven Iterative Revision of Bone Marrow Ancillary Testing Guidelines Improves Test Utilization and Decreases Costs. Mod Pathol 26(Suppl. 2):360A (1508), 2013. e-Pub 2013.
116. Long DJ, Kim AS, Li S. Diagnostic and Prognostic significance of CD200 Expression in Plasma Cell Myeloma. Mod Pathol 26(Suppl. 2):342A (1433), 2013. e-Pub 2013.
117. Li S, Shaver A, Head D. Myeloproliferative neoplasm with FGFR1 abnormality [t(8;17)(p12;q11.2)], 2013. e-Pub 2013.
118. Li S, Seegmiller A, Lin P, Medeiros LJ. High-Grade B-Cell Lymphomas with Concurrent MYC and BCL2 Abnormalities Other than Translocations Behave Similarly to MYC/BCL2 “Double Hit” Lymphomas. Mod Pathol 26(Suppl.2):341A (1429), 2013. e-Pub 2013.
119. Hooper KK, Li S, Mukhtar F, Eltoum IE. Diagnostic Error Assessment of EUS-FNA of Neuroendocrine Neoplasms of the pancreas. Mod Pathol 26(Suppl. 2):92A (377), 2013. e-Pub 2013.
120. Li S. Pure Erythroid Leukemia Mimicking Megaloblastic Anemia in a Bone Marrow, 2013. e-Pub 2013.
121. Long DJ, Li S. Pure Erythroid Leukemia Mimicking Megaloblastic Anemia in a Bone Marrow: A Potential Diagnostic Pitfall. American Society of Clinical Pathology Annual Meeting, Boston, MA, 2012. e-Pub 2012.
122. Xu J, Li S. T Lymphoblastic Leukemia with t(9;22): Blast Phase of Chronic Myelogenous Leukemia or BCR-ABL POSITIVE T-ALL?. American Society of Clinical Pathology Annual Meeting, Boston, MA, 2012. e-Pub 2012.
123. Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic Syndrome/Acute Myeloid Leukemia with t(3;21)(q26;q22) Are Commonly Therapy Related Diseases Associated With Poor Outcome. Mod Pathol 25(Suppl. 2):351A (1472), 2012. e-Pub 2012.
124. Mukhtar F, Magee SH, Li S, Eltoum I. Grading and Staging of Pancreatic Endocrine Tumor: EUS-FNA-Based Compared to Surgical Pathology. Mod Pathol 25(Suppl. 2):99A (405), 2012. e-Pub 2012.
125. Li S, Zuo Z, Bueso-Ramos CE, Yin CC. FLT3 mutation in a case of T-lymphoblastic leukemia with aberrant CD117 expression. 2011 ASCP Annual Meeting/WASPaLM World Congress, Las Vegas, NV, 2011. e-Pub 2011.
126. Li S, Feng X, Lin P, Konoplev S, Medeiros LJ, Yin CC. Extranodal NK/T-cell Lymphoma, Nasal Type, A Retrospective Study of 50 Cases from the United States. MOd Pathol 24(Suppl. 1):307A, 2011. e-Pub 2011.
127. Jaco J, Chen L, Li S, Lin P, Chen W, Miranda R, Konoplev S, Medeiros LJ, Yin CC. CD5-Positive MALT Lymphoma: A Clinicopathologic Study of 14 Cases. Mod Pathol 24(Suppl. 1):302A, 2011. e-Pub 2011.
128. Lu G, Li S, Alseraye F, Muddasani R, Abruzzo L, You MJ, Medeiros LJ. Plasma Cell Myeloma with IGHV Deletion: A Subset of Patients with Poor Prognosis. Mod pathol 24(Suppl. 1):308A, 2011. e-Pub 2011.
129. Li S, Lin P, Fayad L, Lennon P, Hu P, Yin CC, Lin E, Medeiros LJ. B-Cell Lymphomas with MYC/8q24 Rearrangements and IGH@BCL2/t(14;18): An Aggressive Disease with Heterogeneous Histology and Poor Outcome. Mod Pathol 24(Suppl. 1):306A, 2011. e-Pub 2011.
130. Li S, Wan M, Cao X, Ren YS. Expression of AIF and HtrA2/Omi in CLL/SLL and DLBCL. Am J Clin Pathol 132:623, 2009. e-Pub 2009.
131. Li S, Jhala D, Jhala N. Mesothelin and B72.3: Can their expression patterns help distinguish neoplastic cysts of the pancreas?. Mod Pathol 22(Suppl. 1):315A, 2009. e-Pub 2009.
132. Li S, Jhala N. Gastric Injury After Microspheres Radioembolization of hepatocellular Carcinoma, 2009. e-Pub 2009.
133. Li S, Jhala N. EUS-FNA and Cyst Fluid Analysis in the Evaluation of Pancreatic Cystic Lesions: A Retrospective Study of 197 Cases. Mod Pathol 22(Suppl 1):137A, 2009. e-Pub 2009.
134. Li S, Huang ST. A New Marker for Relapsing/recurrent Thrombotic Thrombocytopenic Purpura. American Society of Clinical Pathology Annual Meeting, Baltimore, MD, 2008. e-Pub 2008.
135. Li S, Reilly SD, Steinkampf JL, Faye-Petersen OM. Hydrops fetalis: a fifteen-year review. Mod Pathol 21(Suppl. 1):7A, 2008. e-Pub 2008.
136. Li S, Huang ST, Marques MB. Thrombotic thrombocytopenic purpura following hepatitis B vaccination. Transfusion 47(Suppl):199A, 2007. e-Pub 2007.
137. Zhu Z, Li S, Green CB, Besharse JC, Preisig PA, Alpern RJ. Acid-induced renal cortical nocturnin expression modulates increased renal acid excretion. J Am Soc Nephrol 16(October):122A, 2005. e-Pub 2005.
138. Li S, Alpern RJ, Preisig PA. Rho A kinase, but not Pyk2, c-Src, or ERK1, 2, function downstream of ET-1/ETB in acid induced NHE3 Stimulation 16(October):122A, 2005. e-Pub 2005.
139. Li S, Preisig PA, Alpern RJ. Acid Activates Pyk2, Which Then Binds to and Activates c-Src 15(October):69A, 2004. e-Pub 2004.
140. Li S, Preisig PA, Alpern RJ. Pyk2 is Necessary for Acid Activation of NHE3 Activity, But Not for Regulation of c-fos mRNA Expression. J Am Soc Nephrol 14(November):15A, 2003. e-Pub 2003.
141. Li S, Zhu S. The Polymorphisms of Four Microsatellites Closely Linked to the Locus for Polycystic Kidney Disease 1 in Chinese Populations:P168, 1998. e-Pub 1998.
142. Li S, Zhu S, Wang H. The Polymorphisms of Two Microsatellites Markers Closely Linked to the Locus for Polycystic Kidney Disease 1 in Chinese Populations. Nephrology 3(Suppl. 1):s335 (P1047), 1997. e-Pub 1997.
143. Bai Q, Li S, Zhu S, Wang H. Genetic Analysis of Adult Dominant Polycystic Kidney Disease in the Largest Chinese Minority Group. Nephrology 3(Suppl. 1):S335 (P1048), 1997. e-Pub 1997.
144. Loghavi S, Wei Q, Ravandi F, Quesada AE, Routbort MJ, Hu S, Toruner GA, Wang SA, Wang W, Miranda RN, Li S, Xu J, DiNardo CD, Daver N, Kadia TM, Issa GC, Kantarjian HM, Medeiros L, Tang G. Optical Genome Mapping Improves the Accuracy of Classification, Risk Stratification, and Personalized Treatment Strategies for Patients with Acute Myeloid Leukemia. European Hematology Association 2024 Congress.
145. Dimopoulos YP, Wang W, Li S, Tang G, Loghavi S, Wang S. MPAL, (T/myeloid) with BCL11B activation. 2024 SH/EAHP.
146. Li S, Tang G, Wang W, Medeiros L, Wang S. MIXED PHENOTYPE ACUTE LEUKEMIA, B/T/MYELOID. 2024 SH/EAHP.
147. Yin CC, Young P, You MJ, Xu J, Medeiros LJ, Li S, Garces S. Ras-associated autoimmune leukoproliferative disorder (RALD): A patient with large cell transformation of mycosis fungoides, plasma cell neoplasm and persistent monocytosis. 2024 SH/EAHP.
148. Li S. CD5-Negative and CD10-Positive Mantle Cell Lymphoma: A Clinicopathologic and Gene Expression Study. 36th European Congress of Pathology (2024).
149. Li S, Xu J, Lin P, Miranda R, Medeiros LJ. HHV8 negative Castleman disease, mixed hyaline vascular variant and plasma cell variant, stroma-rich, with progression to B-cell lymphoma. 2024 SH/EAHP.
150. Er S, Li S, Hu S, Guo M, Xu J, Medeiros LJ, Lin P. Adult Onset Familial Hemophagocytic Lymphohistiocytosis with Heterozygous Mutations of PRF1 and STXBP2 following CAR-T Therapy for Diffuse Large B cell Lymphoma. 2024 SH/EAHP.

Book Chapters

1. Tooze R, Lorenzo Leoncini AR, Macon WR, Lenz G, Tamaru J, Momose S, Gopal A, Li S, Dunleavy K, Barrans SL, Davies AJ. Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements. In: WHO Classification of Tumours of Haematolymphoid Tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; WHO classification of tumours series, 5th ed. Available from:https://tumourclassification.iarc.who.int/chaptercontent/63/161. WHO Press, 2022.
2. Klapper W, Ferry JA, Medeiros L, Naresh KN, Hermine O, Rosenquist R, Stilgenbauer S, Rule S, Li S, Lossos IS. Mantle cell lymphoma. In: WHO Classification of Tumours of Haematolymphoid Tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; WHO classification of tumours series, 5th ed. Available from:https://tumourclassification.iarc.who.int/chaptercontent/63/138. WHO Press, 2022.
3. Leoncini L, Delabie J, Rosenwald A, Siebert R, Naresh KN, Dave SS, Ennishi D, Li S, Dunleavy K. High-grade B-cell lymphoma, NOS. In: WHO Classification of Tumours of Haematolymphoid Tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; WHO classification of tumours series, 5th ed. Available from:https://tumourclassification.iarc.who.int/chaptercontent/63/163. WHO Press, 2022.
4. Xu J, Li S, You JM. Bladder Lymphoma and Leukemia. In: Urinary Bladder Pathology. 1st. Springer, 2021.
5. Li S, You J. Large B-Cell Lymphoma with Underlying Chronic Lymphocytic Leukemia (Richter Transformation). In: Case Studies in Hematology and Coagulation. ASCP Press, 2019.
6. Li S, Yin CC. Myelodysplastic Syndrome. In: Precision Molecular Pathology of Myeloid Neoplasms. 1st. Springer, 2017.
7. Li S, et al. Urinary Tract Infections. In: Handbook for General Practitioners, 1999.

Letters to the Editor

1. Dimopoulos YP, Wang W, Wang SA, Loghavi S, DiNardo CD, Gerstein Y, Hu S, Tang Z, Ilagan CJL, Thakral B, El Hussein S, Xu J, Li S, Lin P, Patel KP, Ok CY, Medeiros LJ, Fang H. The spectrum of hematologic neoplasms in patients with Li-Fraumeni syndrome. Am J Hematol 99: 2416-2419, 2024.
2. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B acute lymphoblastic leukemia/lymphoma. Haematologica 108: 895-899, 2023.
3. Fang H, Wang SA, Khoury JD, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Kadia T, Medeiros LJ, Wang W. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica 107: 2232-2237, 2022.